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ABSTRACT 
Purpose. To study the possible roles of p53, its-related proteins, and clusterin in light-
induced photoreceptor cell death in rats. 
Methods. Lewis albino rats were exposed to green fluorescent light (490 - 580 nm) of 
300 - 320 foot-candles (3228 - 3443.2 lux) for 3 hours, allowed to recover in the dark 
and euthanized at 0, 1，3, 6, 12, 24 or 96 hr. Immunohistochemistry was used to detect 
p53, p21, bax, c-fos and clusterin protein. Expression of p53 and bax mRNA was 
detected by in situ reverse transcriptase - polymerase chain reaction (RT-PCR). Nicked 
DNA was detected by in situ terminal deoxynucleotide transferase-mediated dUTP-
biotin nick end labeling (TUNEL). Double-labeling ofp53 or p21 with DNA nicks was 
also performed. 
Results. There was a biphasic up-regulation of p53 protein and its mRNA after photic 
injury. Double-labeling revealed a majority of the p53-immuno-negative nuclei were 
TUNEL-positive. The appearance of p21 protein paralleled p53 showing biphasic 
response. Double-labeling study showed perinuclear staining ofp21 and TUNEL at late 
time points. The appearance of bax also paralleled p53. There was accumulation of c-
fos immunoreactivities (IRs) in scattered photoreceptor nuclei with a time course 
parallel that of TUNEL-positive nuclei. No significant changes of IRs except at late 
stage which showed moderate IRs in the injured area ofthe outer nuclear layer (ONL). 
The number of TUNEL-positive nuclei increased significantly from 0 to 24 hr and 
decreased by 96 hr. Significant thinning of the ONL at the posterior retina was noted at 
96 hr. 
Conclusions, There was a biphasic changes in p53 and p21 after light injury: an early 
increase that may be related to a generalized response to stress; and a late increase may 
be associated with recovery. The early expression of p21 may be related to cell cycle 
arrest while sequestration of p21 may be a prerequisite for or in response to DNA nicks. 
Expression ofbax alone appeared not to be associated with apoptosis. Accumulation of 
c-fos appeared to associate with DNA nicks. Clusterin seemed to play a role in tissue 
repair and remodeling but not in cell death. The results of double-labeling of p53 and 
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TUNEL suggested that there was a narrow window between suppression of p53 and 
presence ofDNA nicks, and proposed that suppression of p53 protein may be necessary 
for the accumulation of c-fos. The results of double-labeling of p21 and TUNEL 
suggested that sequestration of p21 protein may be necessary for the progression of 
apoptosis. Hence, we proposed that p53 and related proteins, but not clusterin, play a 
pivotal role in maintaining the integrity of photoreceptor cells in rat retinas. 
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摘要 
目的：研究其相關蛋白（口21’5&乂及0-{08)及凝集因子 
( C l u s t e r i n)，在光介導的大鼠感受細胞死亡中可能起的 
作用。 
方法： L e w i s白化大鼠暴露在強度為 3 0 0 - 3 2 0 场光（ 3 2 2 8 -
3 4 4 3 . 2 l u x ) 的綠色榮光（波長 4 9 0 - 5 8 0 n m ) 中 3 小 
時’然後在黑暗中恢復，於第0 ’ 1，3 ’ 6 ’ 12，24或 
9 6小時無痛處死。用免疫組織化學方法檢測 0 5 3， p 2 1 ’ 
b a x ’ 0 - { 0 3及凝集因子等蛋白質。用原位及相轉錄鍵 
式反應（ R T - P C R ) 檢測 p 5 3 和 b a x 的 m R N A 表達’點 
連缺口DNA是用原位未端脫氣核糖核酸轉移介導4肌？ $k 
連缺口標記法（ 1 ^ { £ 0檢測’用雙標記方法檢測？ 5 3或 
p 2 1 與 D N A 點連缺口的關係。 
結果：在光損傷後’ ？53 0^^^人及其蛋白質的上游調節存在兩期’ 
雙標記法顯示大部份 p 5 3免疫染色陰性在細胞核表現 
T U N E L 陽性 � ？ 2 1 的表達與 p 5 3 的表達平行，也存在 
兩期。雙標記法表明在晚期核周 p 2 1顯色的細胞核相 
應於 T U N E L陽性。凝集因子的免疫組化結果沒有顯著 
性改變’除了在晚期外核層（0{«^顯示中等度的免疫組 






p 2 1於初期的表達可能抑制細胞周期’而 p 2 1於後期的 
表達可能是DNA¾鍵缺口之需或而對其反應。單獨的匕3乂 
表達與細胞调亡無關� c - f o s的聚集可能與 D N A點鍵缺 
口相關。凝集因子可能在細胞修補或再塑中起作用，而 
與細胞死亡無關。雙標記 p 5 3 和 T U N E L 提示’存在 
於p 5 3的抑制和D N A點鍵缺口標記之間的時相極短，關 
於 p 5 3 抑制作用可能是 c - f o s 聚集所必需品的。 雙 
標記 p 2 1 和 T U N E L 顯示 p 2 1 由細胞核的釋放可能是細 





3-ABA 3 -amino-benzamide 
AP-1 Activator protein - 1 
CKI Casein kinase I 
CKII Casein kinase II 
CO2 Carbon dioxide 
DAB 3,3'-diaminobenzidine 
DHA Docosahexaenoic acid 
DNA Deoxyribose nucleic acid 
DPK Double-stranded DNA-dependent kinase 
H&E Haematoxylin & Eosin 
H2O2 Hydrogen peroxide 
IEGs Immediate early genes 
J« situ RT-PCR In situ reverse-transcriptase PCR 
INL Inner nuclear layer 
IPL Inner plexiform layer 
IRs Immunoreactivities 
IS Inner segments 
JNKI c-jun kinase 
MMS Methyl methanesulfonate 
NFL Nerve fiber layer 
NNA N-nitro-arginine 
NO Nitric oxide 
NOS Nitric oxide synthase 
ONL Outer nuclear layer 
OPL Outer plexiform layer 
OS Outer segments 
PARP Poly-adenosyl-ribose polymerase 
PBS Phosphate buffered saline 
PCNA Proliferating cell nuclear antigen 
PCR Polymerase chain reaction 
PKC Protein kinase C 
rd Retinal degeneration 
RGCL Retinal Ganglion cell layer 
ROS Reactive oxygen species 
^ E Retinal pigment epithelium 
RS Reaction signal 
tdt Terminal deoxynucleotide transferase 
TFIIH Transcription factor II H 
TUNEL tdt-mediated dUTP-biotin nick end labeling 
^ A D Ac-Tyr-Val-Ala-Asp.CMK 
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INTRODUCTION 
The photoreceptor cells are securely situated in the interior of the eye, well 
protected by the sclera, nourished by the uvea and vitreous, and safeguarded by the 
blood-retinal barriers of the retinal pigment epithelium and the retinal vasculature -^^ . 
However, because their primary function is light perception. Therefore, it is not 
surprising that light can be a common cause of physical insult to the retina. 
In 1916，Verhoeff and Bell first noted that radiant energy may damage the 
retina4. Indeed, photoreceptor cells can be easily damaged by chronic environmental 
or artificial lighting at homes, offices, and public buildings5,6 . Light emitted from 
operating microscopy7-9, overhead surgical lamps'®, fundus cameras", slit lampsi。， 
intraocular fiber optics'2 or other direct or indirect ophthalmic instmmentsii,i3-i5 has 
been reported to cause irreversible light damage to patients's retinas during surgery 
or examination. In addition, cumulative light damage to the photoreceptor cells over 
an individual's lifetime may cause significant loss of these neurons resulting in 
visual impairment. As photoreceptor cells are neurons of the central nervous system, 
they are terminally differentiated and cannot regenerate once being destroyed. 
Patients may not be aware of the damage until days after initial insult because the 
light damage is characterized by a minimal initial response, but is followed by a 
degenerative process with loss of photoreceptor cells. 
Light-induced photoreceptor cell death in albino rats and monkeys were 
extensively studied at the 70's and 80,si6-29. it has also been studied in dogs^o, 
cats3i，rabbits32-34, pigeons^o, fishes^s, frogs^^, rainbow trouts37, chickens^s and 
Yucatan miniature pigs��Recently，there are newed interests in light-damage in 
rats and mice to examine the genetic regulations of photoreceptor cell death and the 
potential effect of therapeutic agents in rescuing the photoreceptor cells40-56. 
Rodents can be inbred so that the genetic factors can be controlled, and provide 
retinal tissues at various stages of the degenerative processes as well as enough 
samples for statistical analysis. However, their retinas contain virtually only rods, so 
retinal degeneration involving cone cells is difficult to study in these animals. 
In this study, green light was used to induce retinal degeneration in Lewis 
albino rats57,58 ’ a model widely used to study the degeneration ofphotoreceptor cells 
over the past several decades46.49,58-70. Age-related macular degeneration (ARMD) is 
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the leading cause of blindness in developed countries such the United States and 
Great Britain?�Owing to its complex and not well-defined pathogenesis, there is no 
exact animal models as well as effective therapy for ARMD. Since ARMD has been 
linked to the chronic exposure of light in some studies72,73, light-induced 
photoreceptor degeneration in rats has been utilized to study ARMD, 
Apoptosis is a mode of cell death in which the cell plays an active role in its 
own demise74. The study of apoptosis, the identification of genes controlling 
apoptosis, and the examination of the mechanisms by which these genes accomplish 
their roles have gained increasing importance. Its occurs not only during retinal 
development75’76，but also in retinal diseases?? such as retinitis pigmentosa78，79， 
ARMD80，glaucoma8i-89, traumatic retinal detachment^o and retinoblastoma^i. 
Hence, studies on apoptosis in the retina are pivotal in understanding the 
neurodegenerative processes, and the development of therapeutic agents. 
p53, a tumor suppressor gene, encodes a cell cycle checkpoint protein (~53 
kDa in molecular weight) that contributes to the preservation of genomic stability by 
mediating either Gi cell cycle arrest or apoptosis in response to DNA damage92-96. 
The roles of p53 in these biological processes have been extensively examined in 
many systems93,95,97-99. However, its roles in post-mitotic cells, such as 
photoreceptors, have not been well characterized. 
The possible roles of p53 in the cascade of programmed cell death have not 
been studied in rat retinas. In mice, Howe et al reported in 1994 that p53 is 
necessary for the HPV16 E7 virus-induced apoptosis of mouse photoreceptor cells in 
a transgenic model of retinoblastomaioo. In contrast, subsequent experiments by 
Hopp et al. and Hafezi et al. suggested that the apoptotic photoreceptor cell death in 
the rd (retinal degeneration) mice is neither p 5 3 nor c-fos-dependenti0u02. 
Nevertheless, recent studies have shown that light-induced apoptosis of 
photoreceptor cells in transgenic mice is p53-independentio3 but c-fos-dependenti04. 
One possible explanation of this discrepancy is that mice photoreceptor cells may 
die through at least two different apoptotic pathways namely "p53 and c-fos-
independent" and "p53-independent but c-fos-dependent”，depending upon the initial 
triggering signals. In the rd mice, the initial triggering signal is originated from the 
genetic defect in rod p-subunit o f the cyclic GMP phosphodiesterasei05 o f the rod 
photoreceptor cells, which is involved in the signal transduction pathway of light 
perception. In light-induced apoptosis of photoreceptor cells, the triggering signal 
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may be the initial oxidative DNA damagei06. However, whether the inhibition of 
light-induced apoptosis of photoreceptors in c-fos knockout miceio4 is due to the 
acute lack of c-fos protein after light damage or rather due to its chronic deficit 
during retinal development, or abnormal changes in the circadian rhythm is not 
known. It was well documented that there was a diumal changes in the 
accumulation of c-fos mRNA in the mammalian retinas, suggesting that this 
transcription factor may be one of the primary regulators of light-dependent gene 
expression in the retina^07 Thus, the use of genetically wild type animals with 
normal retinal development and rhythmicity in our study may help to clarify the 
roles ofp53 and c-fos in light-induced apoptosis of photoreceptor cells. Since it was 
demonstrated that light damage to the mice photoreceptor cells was able to trigger a 
p53-independent but c-fos-dependent apoptotic pathwayi03，i04，we postulated that the 
photoreceptor cells in our rat model also die through a similar c-fos-dependent and 
p53-independent pathway after photic injury as in mice. 
Clusterin is a multi-functional protein whose exact functions are not clear. 
This protein accumulates during the regression of the prostate and other hormone-
dependent tissues after hormone ablation and plays a controversial role in apoptosis. 
Clusterin is present in ocular tissues including the comea, ciliary body, aqueous, 
vitreous, lens, retinal ganglion cell and inner nuclear layer, as well as the retinal 
pigment epitheliumio8. The proposed physiological function of clusterin in the eye 
is to modify the biochemical processes at fluid-tissue interfaces such as aqueous-
ciliary body and vitreous-retina/retinal pigment epithelium (RPE)i09. it was known 
that clusterin may also stabilize vitamin A or favor vitamin A transport between the 
retina and the RPEi09,iio. jt has been shown that clusterin is up-regulated in tissues 
that are associated or not-associated with apoptosis in rd (retinal degeneration) and 
油 ( r e t i n a l degeneration slow) micei", as well as light-induced retinal damage in 
albino ratsH2. However, it is not clear if indeed clusterin is involved in 
photoreceptor cell death. 
Here we examined the possible roles of p53, p53-related proteins and 
clusterin in light-induced photoreceptors degneration in rats by using 
immunohistochemistry, in situ reverse transcriptase - polymerase chain reaction 
(RT-PCR)ii3,ii4 and in situ terminal deoxynucleotide transferase-mediated dUTP-
biotin nick end labeling (TUNEL)"5. 
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LITERATURE REVIEW 
I. MODELS FOR STUDYING PHOTORECEPTOR CELL DEATH 
Albino ratH6, miniature poddleii7 and Wag/Rij rat;i7 have been used to study 
the degeneration of photoreceptor cells. For the study of photoreceptor dysplasia, 
the Irish Setter dog"8,"9, Collie'20, rdi21, rds mouse27.i22 and vitiligo (C57BL/6-
mi^ 'Vmi^ '^ ) mouse'23 have been used. The retinal dystrophic Royal College of 
Surgeons (RCS) rat has also been used extensively to study the pigment epithelium-
choroid diseases that lead to photoreceptor cell lossi24,i25 por retinitis pigmentosa, 
transgenic mice^26,i27 and pigs'28-i3i with mutations in the rhodopsin gene have been 
utilized. 
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II. PHOTIC RETINOPATHY 
Since 1916, Verhoeff and Bell had noticed radiant energy may cause damage 
to the retina and led to solar retinopathy^. At that time, they believed that solar 
retinopathy was photocoagulative in nature because ofheat. However, later study by 
Vos showed the retinal temperature rose only 2 °C during sun-gazing'32 and it was 
insufficient to produce coagulative damage. Further experiments suggested that 
solar retinopathy was actually photochemical instead of photocoagulative in 
nature6’i8’20，2i’i33. in 1966, Noell first reported visible light at intensities far below 
the threshold for thermal effects was damaging to the retinas of albino rats, and 
causing loss of photoreceptor c e l l s " 6 . Since then, extensive studies have been 
conducted to investigate this pathophysiological degeneration of the rats retinas 
because it was known that the repetitive mild photic injury to the retina over an 
individual's life time was one of the risk factors in developing age-related macular 
degeneration (ARMD) which was the leading cause o fbl indness72 ,73 . 
Damage to the retina by radiant energy can be classified into three major 
types including mechanical, photocoagulative, and photochemical injury3o，i33. i^ 
mechanical injury, the retina is damaged by sonic transients and gaseous formation 
when extremely high intensity of light, such as those emitted by Nd-YAG (1064-
nm) laser, is absorbed. In photocoagulative injury, the absorbed light emitted by 
argon, krypton, or dye laser raises retinal tissue temperature more than 10 °C, 
resulting in coagulation of retinal proteins. In photochemical injury, light of the 
visible spectrum initiates certain photochemical reactions and leads to degenerative 
changes in the retinas without elevating the tissue temperature. In the following 
paragraphs, we will describe the proposed mechanisms, factors and pathology of 
photic retinopathy that was photochemical in nature. 
II.1. Proposed Mechanisms of Photic Retinopathy 
Even there was variation in factors affecting photic retinopathy among 
different species, in general, the damaging effect was a function of decreasing 
wavelength and increasing exposure duration^Hiss 
The regional differences in susceptibility of the retina to photic injury was 
well documented in rats22，23,i36. The photoreceptors in the superior and temporal 
quadrants of the rat retinas always sustained more severe damage than did the 
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inferior and nasal quadrants. The area at 1.88 mm superior to optic disk was usually 
the most susceptible region to be damaged after photic injury24. There were 
evidences to suggest that photic injury is rhodopsin-mediated. It was reported that 
the action spectrum of photic injury is close to the rhodopsin absorption spectrum 
with a maximum at 480 nm^^.i^s.n? and there is 47 % more rhodopsin (in 
concentration) in the superior than the inferior quadrants of the rat retinas^^. The 
history of light and dark exposure also affects the response to retinal photic injury. 
Rats reared in cyclic light are more resistant to photic injury than rats that are dark-
adapted for 24 hours before light exposure'38-i40 suggesting that the elongated outer 
segments may contain substances that enhance photochemical reaction. Feeney et 
al. first proposed that light exposure might produce a series of free radicals that react 
with polyunsaturated fatty acids, such as docosahexaenoic acid (DHA), in the outer 
segments, which are the preferable substrates for lipid peroxidationi4i，i42 jt was 
also proposed that the free radicals are generated in the highly oxygenated area of 
the outer segments where light energy is perceived by a number of retinal 
photosensitizers, such as riboflavin, retinal, and cytochrome c. When these 
photosensitizers absorb excessive light energy, they are elevated to the singlet and 
later to the triplet state. The singlet state is short-lived while the triplet state is 
relatively long-lived. Photosensitizers in the triplet state may then undergo two 
types of reactions. In the type I reaction, the activated photosensitizers react with 
substrates in the tissue and lead to the formation of free radicals. While in the type II 
reaction, the photosensitizers in the triplet state may react with oxygen, forming 
singlet oxygen and a small amount of superoxide radicals. The free radicals may 
react with DHA in the outer segments, resulting in lipid peroxidation36，i4i-i46，and 
initiate a cascade of tissue damage that involve apoptosis of photoreceptor cells69. 
Rats given antioxidants or free radical scavengers such as vitamin C25’4i’44’i47-i49，p_ 
carotene54，i50，dimethylthiourea40，48，desferri0xamine^ 2^ a-tocopheroP4>56,i5i and 
WR-779i343 showed more resistance to light damage than did rats fed with normal 
diet. It was suggested that these antioxidants may quench singlet oxygen and free 
radicals, and hence prevent lipid peroxidation. These experiments on antioxidants 
and free radical scavengers forther confirmed that the singlet oxygen and oxygen-
free radicals may play an important role in the pathogenesis of photic injury. 
II.2. Factors Affecting Photic Retinopathy 
Experiments in the rats showed a variation of factors that may regulate the 
response to light damage. Elevated body temperature during exposure caused more 
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severe damage to the retina^^^-iss Pre-exposure light history such as dark adaptation 
for 24 hours increased the extent of damage to the retina after photic 
retinopathyi4o,i56 Rats with advancing age were less resistant to light damage^^? 
Gender and diet also affected the severity of the light damage on the retinasi38,i56-i59 
Pigmentation of the iris and retinal pigment epithelium^-i62 affected the severity of 
retinal photic injury probably by lowering the irradiation energy on the retina. 
Susceptibility to light damage also depended on the genetic composition^^.127,163,164 
Growth or neurotrophic factors such as basic fibroblast growth factor (bFGF), brain 
derived neurotrophic factor (BDNF), ciliary neurotrophic factors (CNTF) have been 
shown to rescue or delay photoreceptor cell death after photic injury45，47’52’53，55 
Another experiment on bFGF suggested that the unique a-2 adrenergic receptor in 
central nervous system (CNS) regulated the expression of bFGF which promotes 
photoreceptors survival^^. In addition, the calcium blocker, flunarizine, has been 
shown to prevent light-induced damage of photoreceptor cels60，67 suggesting that 
calcium may has an important role in the pathogenesis of phtoreceptor cells after 
photic injury. 
II.3. Pathologic Processes ofPhotic Retinopathy in Rat 
According to NoelP，photic retinopathy can be classified into two types. 
Type I was characterized by the loss of both retinal pigment epithelium and 
photoreceptor nuclei while type II was characterized by the sole loss of 
photoreceptor nuclei. 
Under light microscopy58,66’ii6’i37，type I injury showed early disruption of 
the outer segments and chromatin densification. This was followed by chromatin 
margination and outer segment vacuolation. The light-induced retinal degeneration 
affected the photoreceptor cells in an asynchronous fashion and was accompanied by 
mild inflammatory reaction at the late stage showing macrophagic infiltrate. 
Hypertrophy ofMuller cell processes was common. In the rats, there could be a loss 
of about 25% photoreceptor nuclei without the appearance of macrophages. The 
macrophages might start a respiratory burst in which a 10-20 fold increase ofoxygen 
was consumed, producing a series of oxygen free radicals, including superoxide 
radicals and hydrogen peroxide. 
Under electron microscopy58, the early nuclear changes after photic injury in 
rats consisted of a central densification of chromatin within which there were 
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scattered islands of liquefaction. Subsequently, nuclear chromatin became 
uniformly dense, while mitochondrial swelling was observed in the cytoplasm 
around the nucleus. Margination of the chromatin to the periphery of the nucleus 
was noted, and associated with further mitochondrial swelling and perinuclear halo. 
Further chromatic margination gave an electron-lucent appearance centrally. Later, 
the chromatin aggregated into circumscribed dense masses that abutted on the 
nuclear membrane. Finally, there was dissolution of chromatin, breaks in the 
nuclear membrane, and disintegration of cytoplasmic contents. These 
morphological features are consistent with the hypothesis that the photoreceptor 
cells die through programmed cell death after photic injury69. 
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III. p53 
III.1. Historical Perspective 
Back in 1979，when the p53 protein was independently discovered by David 
Lane and Arnold Levine, almost no one would think of nominating it for the 
"Molecule ofthe Year". The 53-kilodalton phosphoprotein was identified from the 
coimmunoprecipitates ofthe extracts from simian virus 40 (SV40)-transformed cells 
with anti-T antibodyi65,i66. it has been shown to form a tight complex with the large 
T antigen of the SV40, a virus that causes cancer in rodents but not in human. 
Subsequently, p53 has been shown to form complexes with adenovirus and 
oncogenic papillomavirus oncoproteinsi67,i68 
In 1982, Jenkins and co-workers isolated the human p53 gene. At first, p53 
appeared to cause cancer rather than suppress it because it could immortalize cells in 
culturei69,no ^nd cooperate with activated ras oncogene to transform cultured 
cellsi7i,i72 Overexpression of p53 also enhanced the transformed phenotype of 
tumor cellsi73. It was thought to act only as an oncogene gene that actively promote 
tumor growth, because investigators were inadvertently working with its mutant 
form. Although oncogenes were extensively examined during the 1980s, there were 
plenty of genes that seemed more promising than p53. Those who sought p53 
mutations in human tumors by the Southern blotting were usually disappointed 
because in contrast to other leading oncogene candidates, p53 expression almost 
always appeared normal. 
It was not until 1989 that p53's true color was discovered. While pursuing 
the genetic causes of colorectal cancer, researchers found a point mutation in p53 - a 
type of mutation undetectable by Southem blotting. In the same year, other 
experiments demonstrated that only mutant p53 genes promoted abnormal cell 
growth while the wild type gene indeed suppressed tumorsi74-i76 since then, p53 
became one of the most studied subjects in cancer research. Human p53 gene was 
named TP53 by some researchers to stand for tumor-suppressor protein while its 
counterpart in mouse"�was named Trp53. 
In 1992, p53 was described as the "guardian of the genome"i77 and in the 
same year, it attained the honor of the "Second Most Significant Scientific Trend of 
the Year" in Time magazinei78. In 1993，p53 was named the “Molecule ofthe Year" 
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by the editors of Science^^ -^^ ^ .^ Since 1979, more than 8,500 papers have been 
published in which the term "p53" appears in the title abstracts. It is likely that 
before 1999，the total number ofpapers may hit 10,000. 
III.2. Structure ofp53 
111.2.1. The p53 gene and mRNA 
The human p53 gene, composed of 16-20 kilobases ofDNA is located on the 
short arm of chromosome 17 at position 17pl3.1i82-i84 it consists of 11 exons with 
the first exon (213 base pairs) as a noncoding mRNA leader sequence (Figure lA). 
The p53 gene is highly conserved across species. Despite humani69,i70，i85, it 
has been isolated from monkeyi86, dogi87, cati88,i89, rabbit, hamsteri9o,i9i^ mti92，i93, 
woodchucki94, ground squirreli94, mousei95, sheepi96, beefi97, pig，horse^, 
donkeyi99, chicken200’20i，Xenopus laevis^, fish203, rainbow trout204, zebrafish205’206， 
mussel and squid207. 
The p53 gene produces a mRNA of2.2-2.8 kilobases in size that is expressed 
in all cells and tissues of the body208. The highest levels ofp53 mRNA are found in 
the thymus, spleen, testes, and ovaries. 
111.2.2. The p53 protein 
The product ofp53 gene is a 393-amino acid nuclear phosphoprotein (~ 53 
kilodalton in molecular weightp5’209，2i0. xhe wild-type p53 protein is found in very 
low quantities in normal cells, but mutant p53 could be detected in large quantities 
(fivefold to hundredfold) in transformed cultured cells as well as human tumor 
cells209. Normally, the half-life of wild-type p53 is about 20 minutesi76,2"-2i3, 
whereas all ofthe missense mutants ofp53 protein often have half-lives ofhours2i4-
216. 
The nucleotide sequence of the gene and the amino acid sequence ofthe p53 
protein is well conserved in vertebrates, but there are no protein homology ofp53 in 
the lower eucaryotic organisms. The p53 proteins ofhuman and mouse share 82% 
homology while those of human and Xenopus laevis have 68% homology. 
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Figure 1: Schematic diagrams of the structure of human p53. (A) Structure 
of human p53 gene and protein: A human p53 gene consists of 11 
exons (El-Ell) and 10 introns (11-110). El and E l l contain non-
transcribed sequences for cDNA (Red box). El, E2 and El 1 contain 
non-coding sequence for the protein (Light blue box). E2 - E l l 
(Blue box) transcribed a p53 protein (393 amino acids) with five 
evolutionary conserved regions (I，II，III，IV and V) with four 
functional domains namely the Transactivation domain, Sequence-
specific DNA binding domain, Oligomerization domain, and 
Nonspecific nucleic acid-binding and reannealing domain. (B) 
Mutational "hot-spots，，of p53: Note the averaged mutations of p53 
mainly clustered in five evolutionary conserved regions (I-V) and in 
the sequence coding for the sequence specific DNA binding domain. 
Three major mutational "hot-spots" in human will lead to missense 
mutations in codons 175, 248 and 273. (C) 3D structure of p53 
protein: The DNA ^>urple) and core domain (turquoise) are shown 
with the zinc atom (Red), with the position of the six hot-spots of 
amino acid residues (yellow). Mutations in hot-spots amino acids 
either interfere with protein-DNA contacts, or disrupted the integrity 
of the domain. Thus, it demonstrates that sequence-specific DNA 
binding is central to the normal functioning of p53 as a tumor 
suppressor gene. (Modified from graphs in 
http://perso. curite. fr/Thiery. soussi/p53 -databases .html). 
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Comparison of the amino-acid sequences of p53 from human, African green 
monkey, golden hamster, rat, chicken, mouse, rainbow trout and Xenopus laevis 
show five highly (> 90%) conserved regions within the amino acid residues 13-19， 
117-142, 171-181, 234-258, and 270-286^17. These five well-conserved domains 
within the coding regions are essential to the function of p53 since they also coincide 
with the mutation clusters found in human cancers. 
The p53 protein contains four main functional modules (Figure lA)2i8,2i9. 
The highly charged N-terminus (residues 1-42) comprises an acidic transcriptional 
activation domain that binds to the promoters of other genes and enhances or 
represses transcription of those gene^^o. The central domain (residues 102-292) is 
the sequence-specific DNA-binding domain of the protein22i-224, carrying most of 
the frequent mutations in cancer cells. Six so-called mutational 'hot-spots', which 
account for 40% ofknown p53 missense mutations have been described (Figure lB 
and lC). The oligomerization domain (residues 324-355) dictates that the protein 
binds DNA as a tetramer^ 23-225_ xhe carboxyl terminus (residues 367-393) is a 
nonspecific nucleic acid-binding and reannealing domain that controls the ability of 
the protein to allosterically switch from a latent form to one that is active for 
sequence-specific DNA binding224,226,227 
p53 has two protease-resistant domains: one within the central portion, 
extending roughly between residues 100 and 290, and another between residues 330 
and 360，corresponding to the DNA-binding and tetramerization regions 
r e s p e c t i v e l y 2 2 U 2 3 The absence of signaling and phosphorylation sites within the 
compactly folded, relatively inaccessible, central portion of the protein is consistent 
with the observations that most anti-p53 antibodies react with epitopes within the N-
and C-termini rather than the central portion228. 
III.3. Modifications ofp53 
The biological activities of p53 can be affected by post-transcriptional andA)r 
post-translational modifications in the mRNA and protein level respectively. 
Increase in the transcriptional rate of the mRNA is one of the major post-
transriptional modifications which increases the half-life of the protein92,229,23o 
Post-translational modifications include phosphorylation or interaction with other 
cellular and viral proteins which regulate its biological act ivit ies226. 
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The p53 protein is known to be phosphorylated by casein kinase I and II 
(CKI and CKII r e s p e c t i v e l y ) 2 3 i - 2 3 4 , double stranded DNA-dependent kinase 
(DPK)235, cyclin-dependent kinases236，237，mitogen activated kinase238, c-jun kinase 
(JNKI)233and protein kinase C (PKC)239. 
CKI and DPK phosphorylate sites in the transactivation domain, and 
simultaneous mutation of these sites to alanine impairs the ability of p53 to activate 
transcription of other genes^^o. DPK is a potential mediator of the response to DNA 
damage, since it is activated by DNA strand breaks, which also activate p53^7. While 
CKII can selectively regulate p53-dependent repression (e.g. c-fos), but not 
transactivation (e.g. p21)24i. 
Despite phosphorylation, DNA binding activities of p53 can be stimulated by 
antibody binding or short single strands of DNA. Recently, a redox/repair protein 
Ref-1 was demonstrated to stimulate the DNA binding and transactivation of a latent 
p53 by both redox-dependent and independent pathways242, suggesting the activities 
of p53 can be modulated by changing its redox state. 
III.4. Functions of p53 
Being the guardian of the genome, the primary biological activity of p53 
protein is to suppress cell proliferation and arrest cells at Gi phase of the cell 
cycle243-247 Over-expression of p53 inhibits the induction of proliferating cell 
nuclear antigen, and blocks cells from entering S phase^^s. 
III.4.1. p53 & tumors 
Mutational inactivation of the p53 gene is recognized as one of the most 
frequent genetic aberrations in human cancer, such as cervical cancer (90%), oral 
mucosa squamous cell cancers (81%), small cell lung cancer (70%), anaplastic 
undifferentiated thyroid cancer (68%) and brain tumor (50%)249,250, 
p53 is currently the best-characterized cell cycle protein linked to genetic 
instability and thus is the focus in cancer research. In cancer cell with wild-type 
p53, a therapeutic goal would be to direct the cells to apoptosis. In cancer cells with 
mutant p53, induction of apoptosis would have to be accomplished by manipulation 
of a biochemical event that is normally downstream of p53 in the apoptotic 
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pathways. Restoration of checkpoint functions in cancer cells with abrogated 
checkpoints is another potential mechanism for minimizing cancer progression. 
Potential approaches in manipulating p53 functions include gene transfection 
techniques and biochemical manipulations that alter the conformation of the mutant 
p53 protein to restore its wild-type fimctions25i-256 Inactivation of the mdm2 
protein, an endogenous inhibitor of p53 function, also provides another target for 
restoring p53 fUnction257. 
III.4.2. p53 & DNA damage 
p53 is implicated as a critical determinant of cell fate following certain types 
of DNA damage, such as ionizing radiation and DNA topoisomerase-targeted 
dmgs97，258,259 Qnc wcll charactcrizcd response of p53 to DNA damage is an 
increase in the half-life of the protein by a post-transcriptional mechanism, resulting 
in a progressive increase in protein levep2,229,230^ thereby arresting the cells at the 
late Gi phase of the cell cycle245,246 xhis may facilitate the maintenance of DNA 
sequence fidelity through repair and prevent the accumulation ofheritable alterations 
of the DNA template. 
ATM ("mutated in ataxia-telangiectasia") and p53 are two gene products that 
are believed to play a major role in maintaining the integrity of the genome229,260 
such that alterations in these gene products may contribute to increased incidence of 
genomic changes such as deletions, translocations, and amplifications, which are 
common during oncogenesis. The ATM gene product appears to act upstream of 
p53，p21 and Gadd45 in the signaling after DNA breakage^^i. Following certain 
cytotoxic stresses, normal ATM function is required for p53-mediated Gi arrest262. 
Structure ofATM gene product showed similarities to the catalytic subunit ofDNA-
dependent protein kinase (DNA-PK)263, suggesting that ATM may modulate the 
activities of p53 by enhancing its phosphorylation. ATM is also involved in other 
cellular processes such as S phase and G2-M phase arrest264,265 and in 
radiosensitivity98，266，267. Studies by subcellular fractionation, 
immunoelectronmicroscopy and immunofluorescence showed that the ATM protein 
was present in the nucleus and cytoplasmic vesicles. Normally, the ATM protein 
was bound to p53 and this association was defective in A-T cells compatible with 
the defective p53 response in these cells268. 
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c-Abl protein tyrosine kinase is activated by certain DNA-damaging 
agents269. Its overexpression causes cell cycle arrest at the Gi phase by 
downregulating cyclin/Cdk2 through p53-dependent but Rb- and p21-independent 
mechanism, although it upregulates the expression of p21 by stimulating the 
transcriptional activity of p5 3 270-272. lt was demonstrated that both the 
antimetabolite 1 -p-D-arabinofuranosylcytosine (ara-C) and the alkylating agent 
methyl methanesulfonate (MMS) induce binding of c-Abl and p53. It was proposed 
that the formation of c-Abl/p53 complex may directly downregulate cyclin/cdk2 
activity273 and enhance p53-dependent transcription o f b a x 2 7 i 
III.4.3. p53 & apoptosis 
Beyond arresting the cell cycle at Gi phase after DNA damage, p53 is 
believed to play a critical role in the induction of apoptosis. Apoptosis may 
processes via p53-dependent or p53-independent pathways. p53-dependent 
apoptotic pathway can be further subdivided into two pathways: one requiring the 
activation of specific target genes while the other is independent on transactivation 
of other genes274,275. Whether the apoptotic activity of p53 depends on its sequence-
specific transcriptional activation properties is still c o n t r o v e r s i a P ^ 6 - 2 7 8 Recent 
evidences have been accumulated to support that p53 can stimulate apoptosis in the 
absence of transcriptional transactivation279. 
III.4.3.1. p53-dependent apoptosis 
The p53-dependent apoptosis has been demonstrated in mouse embryonic 
fibroblasts280’28i，Burkitt lymphoma (BL) cell line that carry a mutant p53282, ocular 
lens during developing in mice283, derivatives of GHFT1 cells274, human SAOS-2 
osteogenic sarcoma cells^^^, human non-small cell lung cancer cell line H358285, 
hepatocyte (TLR2) and kidney tubule (TKC2) cell lines immortalized with 
temperature-sensitive SV40 large T-antigen gene286, retina of a transgenic mouse 
nu)del with retinoblastomaioo，adenosine deaminase deficiency-induced apoptosis of 
thymocyte287, ElA-induced apoptosis in baby rat kidney (BRK) celP^s and small 
cell lung cancer (SCLCp9. 
Recent studies suggested that the C-terminal region of p53 protein (amino 
acid 320-393) plays an important role in p53-mediated DNA damage and apoptosis. 
It binds to damaged DNA29o,29i, reanneals DNA and RNA292，293，inhibits 
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transcription in transfection assays294, carrys transforming potentiaP5,2%, restores 
the apoptotic response when directly microinjected into primary normal human 
fibroblasts297, and most interestingly, restores DNA binding activity to a subset of 
p53 mutants both in vivo and in vitro^^^. It also inhibits both helicases of the 
transcription factor IIH (TFIIH) complex299. The TFIIH complex phosphorylates 
RNA polymerase II (po\ II) and has a role in RNA polymerase II transcription300’30i， 
DNA repair302, and possibly cell cycle controP03. 
Calpain304，305，a calcium activated protease, can cleave p53 to several 
fragments, probably by releasing the C-terminal region279,306-309. These activities 
can be inhibited by chelating the Ca^^ ions, by specific cysteine protease inhibitors 
or by peptide aldehyde derivatives that inhibit calpains. Calpain also degrades N-
myc，c-fos and c-jun, but not lysozyme307. Proteolytic cleavage of p53 occurs d u r i n g 
UVB radiation-induced apoptosis in transfected human cell line that overexpress 
R273H mutant p53. This cleavage generates a 45-kDa fragment and liberates the 
DNA repair helicase binding domain of p53. It may therefore contribute to its 
apoptotic activity, probably through interaction with the XPB and XPD DNA 
helicases. 
p53 as a transactivator or repressor in apoptosis 
The literatures showed that p53 can function in a totally opposite ways, 
either as a transactivator or repressor of apoptosis by binding either a p53-enhancer 
or p53-repressor elements in the promoter region of some candidate genes involved 
in apoptosis. 
The p53 protein can repress the promoters regulating the interleukin-63io, c-
fos3"，c-jun3ii, p-glycoprotein3i2, bcl-23i3,3i4 and iNOS^is, or stimulates 
transcription of mdm23i6,3i7, bax27Ui8，3i9，Gadd45229，p2p20^  Rb32i, Fas/APO-
1/CD95219,322,323, Cyclin 0^24, IGF-BP3325, PAG68 0326, HUMSIAH327,328, 
phospholipase C p432s, homologue of multiple endocrine neoplasia I (ZFM1) 
candidate genes^^s and A28-RGS14329. Upstream regulators of p53, such as ATM, 
c-Abl, and Ref-1242，270-272，may also involve in p53-mediated apoptosis. Recent 
study has also shown a set of p53-induced mRNA that may be involved in p53-
dependent apoptosis330. 
p53 as a transactivator in apoptosis 
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The mechanism by which elevated p53 levels lead to apoptosis is not known, 
but is believed to involve transcriptional activation of downstream genes linked to 
apoptosis, such as bax27i,33U32 
p53 also transactivates mdm2 gene. The mdm2 oncogene encodes a 90-kDa 
protein that binds to the p53 tumor suppressor protein and negatively regulates its 
function in transcription, cell cycle arrest, and a p o p t o s i s 3 3 3 . The mdm2 gene is 
frequently amplified in human sarcomas, which may be responsible for the 
malignant transformations. Evidences have shown that the mdm2 oncoprotein is 
cleaved by an interleukin ip-converting enzyme-like protease (caspase) during p53-
mediated apoptosis. The protease that cleaves mdm2 has a specificity similar to that 
of CPP32 (caspase-3), and recombinant caspase-3 is able to cleave mdm2 in vitro. 
The protease cleavage site has been mapped between residues 361 and 362 in the 
human mdm2. The proteolytic cleavage removes the COOH-terminal RESlG fmger 
domain of mdm2, resulting in the loss of RNA binding activity. However, the p53 
binding and inhibitory functions of mdm2 are not affected by the cleavage. The 
cleavage site sequence of mdm2 is evolutionarily conserved, suggesting that 
caspase-mediated cleavage of mdm2 during apoptosis is important to exert its 
biological a c t i v i t i e s 3 i 6 , 3 i 7 . 
A 21-kDa protein, variously known as Cipl (for cyclin-dependent kinase 
(Cdk)-interacting protein334), sdil (for senescent cell-derived inhibitor335 and Wafl 
(for wild-type p53-activated fragment320) that inhibits cyclin-Cdk complex kinase 
activity334 has been identified by three groups, p21 is a critical downstream effector 
in the p53-specific pathway of growth control in mammalian cells336-339 The 
participation of p21(Wafl/Cipl) in p53-triggered cell death remains controversial. 
Some studies have shown that elevated p21 expression in K562 cells with mutant 
p53 did not promote apoptosis340. It has been demonstrated that p53 overexpression 
is highly toxic for p21-deficient mouse embryonic fibroblasts (p21-/- MEFs)34i, 
suggesting p21 expression may be required for survival in p53-induced cell death. 
The p21 protein may also involve in the execution of programmed cell death. 
p21 up-regulation at both mRNA and protein level is seen in quiescent mouse 3T3 
fibroblasts stimulated to die by serum deprivation. In addition, this up-regulation of 
p21 is functionally related to the operational efficiency of the apoptotic process, in 
that when cells are transfected with an antisense construct to repress the endogenous 
p21-protein level, death is delayed. Quantitative protection from apoptosis with 
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antisense p21 transfection is relatively proportional to the repressed level of this 
protein in the cells suggesting that the apoptotic-dependent additional increase of 
p21 beyond the baseline, as seen in serum-deprived quiescent cells, may be involved 
in apoptotic cell death342. 
Gadd45 (growth arrest and DNA damage inducible)343 was originally 
isolated from hamster cells and grouped together with four other genes that 
demonstrated a coordinated and rapid induction by agents producing high levels of 
basic damage in DNA. Gadd45 is an ubiquitously expressed mammalian gene that 
can be induced by DNA damage and certain other stress through transactivation by 
p53. Like p21, Gadd45 has been associated with growth suppression but not 
mediated by inhibiting the kinase activity of multiple cyclin/Cdk complexes. Despite 
cell cycle arrest, Gadd45 also enhances DNA excision repair. Both activities may 
directly attribute to its interaction with proliferating cell nuclear antigen (PCNA). 
The role of p53 in activating these responses remains to be determined and the 
possible role of Gadd45 and p53-dependent apoptosis is not clear. 
p53 as a repressor in apoptosis 
c-fos gene, one of the most extensively studied immediate early genes 
(IEGs), was originally found in mutated forms in two acutely oncogenic murine 
retroviruses: the Finkel-Biskis-Jinkins (FBJ-MSV) and the Finkel-Biskis-Reilly 
(FBR-MSV) osteogenic vimses344，345. The c-fos protein is known to be a 
transcriptional factor defining a multigene family and requiring interaction with 
other transcriptional effectors. The most famous of these are c-jun proto-oncogene 
family members that associate with c-fos protein and lead to formation of AP-1 
(Activator protein 1) transcription complex. Sustained c-fos gene expression is 
limited to specific cell types both in vivo and in vitro. However, it can be induced 
rapidly and transiently in all cell types by short-term stimuli but resulting long-term 
response, such as growth, differentiation and nervous adaptive phenomena. It was 
known that wild-type p53 can down-modulate the activity of various promoters, 
including c-fos^n, IL-63" and iNOS3i5. It was also demonstrated that wild-type 
p53，but not mutant p53, negatively regulates the activity of the c-fos promoter in a 
dose-dependent manner346. 
Exposure ofhuman cells to Nitric oxide Q^0) generated from a NO donor or 
from overexpression of inducible nitric oxide synthase (iNOS) results in p53 protein 
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a c c u m u l a t i o n 3 i 5 . In addition, expression of wild-type p53 in a variety of human 
tumor cell lines, as well as murine fibroblasts, results in down-regulation of iNOS 
expression through inhibition of the iNOS promoter. It was suggested that p53 
accumulation which safeguards against DNA damage by p53-mediated repression of 
iNOS gene expression, thus reducing the potential ofNO-induced DNA damage^is. 
Another study revealed that NO induced nuclear accumulation of p53 protein in a 
dose- and time-dependent manner in human and rat cancer cells. It was reported that 
the activation ofp53 by NO may be regulated by the post-translational modification 
0 f p 5 3 3 4 7 . 
r>tW pS^-induced genes 
Resent study by Polyak demonstrated a set of genes, so called PIGs (p53-
induced genes), that was expressed in colorectal cancer cell DLD-1 in which wild 
type p53 was overexpressed^^o. Whether all PIGs were transcriptionally activated by 
p53 was not known, but some of the encoded proteins were known to have activities 
that related to the redox status of the cells. For example, one of the induced genes is 
a novel member ofthe microsomal glutathione S-transferase gene family. One is the 
human homologue of a mouse quinone gene known to generate reactive oxygen 
species (ROS). Another one is a homologue of proline oxidoreductase, a 
mitochondrial enzyme that catalyses the first step in the conversion of proline to 
glutamate. Glutamate is one of the three amino acids required for formation of 
glutathione, which is a major regulator of cellular redox status. One of the PIGs is a 
relative of NADPH-quinone oxidoreductase which is a potent generator of ROS. 
Since reactive oxygen species are potent inducer of apoptosis348’349，p 5 3 may induce 
apoptosis by stimulating the production ofROS through the transcriptional induction 
of redox-related genes. Consequently, the cell may die through the oxidative 
degradation of mitochondrial components 
III.4.3.2. p53-independent apoptosis 
Despite evidences that support a p53-dependent apoptotic pathway, the p53-
independent apoptosis has also been demonstrated in many cell types. It has been 
reported in sodium butyrate induced apoptosis in human colonic tumor cells^so and 
in SV40 large T antigen-transformed temperature-sensitive BN462 cells35i. p53. 
independent apoptotic and necrotic cell deaths induced by adenovirus infection was 
also demonstrated in ElB 19k -transfected human Saos2 and mouse p53 nullizygous 
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(p53-/-) cells lacking the p53 tumor suppressor protein352. Another independent 
study showed gamma-radiation- induced apoptosis in human colorectal adenoma and 
carcinoma cell lines in the absence of wild type p53353. 
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IV. CLUSTERIN 
IV.1. Historical Perspective 
Clusterin also called testosterone-repressed prostate message 2 (TRPM2)354, 
apolipoprotein J (apoJ)355’356，"SP40, 40"357, complement lysis inhibitor35S, 
Glycoprotein IIP59, T64360, pADHC-936i, gp 80^62, NAl/NA2363, pTB16364, 
K611365，and pc38K366 by various investigators. It is a glycosylated and sulfated 
protein first purified in 1983 from ram rete testes fluid as a protein that elicits 
clustering of Sertoli cdls367,368 since then, species homologues of clusterin have 
been isolated or cloned by a number of groups working with different tissues. The 
rat homologue of clusterin, initially termed dimeric acidic glycoprotein (DAG) and 
later sulfated glycoprotein-2 (SGP-2), was isolated from Sertoli cells and several 
other locations of the rat reproductive system, such as the stereocilia of epididymal 
principle cells, the acrosome and tail region of most spermatozoa and prostate369-378 
IV.2. Structure ofClusterin 
IV.2.1. Clusterin gene and mRNA 
The human clusterin gene is located on chromosome 8p21 and transcribes a 
mRNA of2 kilobases mRNA379-38i. The clusterin gene is organized into nine exons, 
ranging in size from 47 base pairs (exon I) to 412 base pairs (exon IV)，spanning a 
region of 16,580 base pairs in human382 and 13,750 base pairs in mt383. 
IV.2.2. Clusterin protein 
The human homologue of clusterin is made up of 449 amino acids and has a 
molecular weight of approximately 80 KDa357,358 ^ [^  ^ heterodimer comprised two 
40 KDa chains that were linked by five disulphide bonds^84 ciusterin has a unique 
structure including a long a-helix motif near the amino terminal that promotes 
dimerization, at least six N-linked glycosylation sites with a high degree of 
sulphation of the attached carbohydrate in certain tissues such as testis and several 
potential heparin-binding structure in the most conserved region (nucleotides 105-
135)355，357’358’384’385. 
IV.3. Functions ofClusterin 
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Clusterin has shown to be constitutively synthesized and secreted by a wide 
variety ofcell types^ss. Although the exact function was not clear, it has been shown 
to have cell-aggregating367,368^ complement-inhibitory357’358，386, lipid-binding363，387-
389 properties, and to be involved in endocrine secretion355,359’390-392，tissue 
r e m o d e l i n g 3 6 i , cellular d i f f e r e n t i a t i o n ^ ， ^ as well as apoptosis. Clusterin has also 
been shown to express constitutively in epithelial cells, which serve as critical 
barriers between harsh biological fluids and tissue^^s. 
IV.3.1. Clusterin & apoptosis 
Increased expression of clusterin was reported in many tissues undergoing 
apoptosis^ 11,394,396^ 18. Howevcr, the exact role of clusterin in apoptosis remains 
unclear. One ofthe proposed functions is its role in lipid transport between cells that 
may provide a mechanism to eliminate excessive lipid derived from dead or injured 
cells or to scavenge toxic lipid byproducts403,4i9 Several studies showed clusterin 
was induced in injuries states that are not always associated with apoptosis420-422, In 
addition, some studies demonstrated that clusterin depletion, instead of its induction, 
was associated with apoptosis. Being an inhibitor of complement-mediated 
cytolysis, it binded to the soluble C5b7 and formed a cytolytically inactive complex. 
This would protect both the apoptotic cells and its vital neighbors from complement 
a t t a c k 3 5 5 , 3 8 1 , 3 8 9 , 4 1 9 . 
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OBJECTIVES 
The goals ofthis study were to examine the temporal sequences ofthe early 
changes in (1) morphology and morphometry, (2) expression of p53 both in the 
protein level with immunohistochemistry and in the mRNA level with in situ RT_ 
PCR; (3) expression of p53-related proteins such as p21, bax and c-fos with 
immunohistochemistry and expression of bax mRNA with in situ RT-PCR; (4) 
expression of clusterin in protein level with immunohistochemistry; and (5) to 
explore the relationship between p53 or p21 proteins and light-induced 
photoreceptor cell death by double-labeling with TUNEL. 
It has been known that light injury to the retinas may involve extensive 
invasion of macrophages into the subretinal space and lead to cell death through a 
complex and non-apoptotic pathways58’66，ii6，i37. in order to minimize the 
participation of macrophages, our first aim was to develop a slow retinal 
degeneration model which was simply apoptotic in nature. We believed that slow 
retinal degeneration may prevent or at least delay the infiltration of macrophages 
into the subretinal spaces. Since the severity ofthe light damage was the ftmction of 
light intensity and duration^34,i35^ we postulated that the rat retinas exposed to high 
intensity of light for a short period would generate a slow degeneration of 
photoreceptor cells with minimal involvement of macrophages. The 3 hours-
continuous green light exposure was selected because, in our preliminary study, 1 
hours-continuous light exposure was not efficient and effective in induction of 
photoreceptor cells lost while 6 hours-green light exposure showed no significant 
difference between those of 3 hours in terms of their outcome. Thus, to prevent 
avoidable stress to the rats, a 3 hours-continuous green light exposure model was 
established. Previous studies usually exposed rat retinas for 12 or 24 hours because 
those studies were examining the protective effect of the potential therapeutic 
agents49，60-62，64’67. Hence, a model with acute and extensive loss of photoreceptor 
nuclei was utilized to detect the difference between treated and non-treated groups. 
p53 is a well known tumor suppressor genei74-n6 n also plays a pivotal role 
in induction of apoptosis in some s y s t e m s i o o , 2 7 4 , 2 8 0 - 2 8 9 i^ our study, in situ RT-PCR 
was applied to detect the low level ofp53 expression in which it has a short half-life 
of about 20 minutesi76,2ii-2i3. p2i, one of the possible downstream effector of p53, 
is a specific cycliny'cyclin-dependent kinase inhibitor in which its accumulation will 
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arrest the cell cycle at Gi phase336-339. Therefore，those strong p21 immuno-positive 
nuclei would be considered as cells with cell cycle arrested at Gi phase. The bax is a 
homologous protein that forms heterodimers with bcl-2 and its accumulation will 
accelerate the rates o f c e l l death in some system33U32. it is k n o w n that the bax gene 
promoter consists ofap53-enhancer element27Ui8,3i9 and therefore bax is one ofthe 
potential mediators of p53 in apoptosis. In situ RT-PCR was also applied to 
investigate the low level expression of bax mRNA in our study, c-fos is an 
immediate early gene that is expressed in response to multiple stimuli3H345. The c-
fos promoter contains a p53-repressor element, and therefore can be inhibited by the 
accumulation ofp533"'346. Morphometry of positive c-fos were performed and its 
results were compared with the morphometry of positive TUNEL. Clusterin is a 
multi-ftmctional secretary glycoprotein mainly detected in the reproductive 
systems355,390-394^  Little is known about its regulation but molecular studies have 
shown that the promoter of clusterin contains the consensus sequence for the 
activating protein (AP-1) transcriptional factor383. Therefore, in our study, we 
examined the possible regulation of clusterin by p53 indirectly through manipulation 
ofc-fos. 
If p53 or clusterin really plays a pivotal role in the molecular pathway of 
apoptotic cell death of photoreceptor cells. Modulation of p53 or clusterin 
expression could therefore represent a novel strategy for therapeutic interventions of 
retinal degeneration. This might extend the survival of the photoreceptors by 
prolonging the period of visual function in diseases that otherwise lead to blindness 
or severe visual impairment. Concurrently, understanding the roles p53 and 
clusterin in cell death in the retina may provide new insights into the molecular 
mechanisms of tumor transformation in retinas and help identifying potential targets 
for therapies. 
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MATERIALS AND METHODS 
V. SAMPLE COLLECTIONS 
V.1. Induction ofPhotic Injury in Rat 
Sixty-four 35-days-old Lewis albino rats [Animal House of The Chinese 
University ofHong Kong] weighting 200-250 grams were equally divided into eight 
groups. The rats were fed with normal diet and reared in 12-hour cyclic white 
fluorescent light (5 foot-candles; 53.8 lux) and darkness for 14 days, followed by 24 
hours of dark adaptation. Groups of four animals were then exposed to continuous 
green-filtered fluorescent light in a Plexiglass chamber [Plexiglass No. 2902 filter, 
Polycast Technology Corp, Stamford, CT, USA] surrounded by seven circular 
fluorescent tubes. The chamber transmitted green light between 490-580 nm and the 
light intensity was adjusted to 300 - 320 foot-candles (3228 - 3443.2 lux). During 
the 3 hour light exposure, the temperature and relative humidity were maintained at 
24 — 26 °C and 60% with constant airflow in and around the chamber. These light 
exposure conditions were determined with preliminary experiments in which light 
intensities and exposure time were varied to obtain a model with slow degeneration 
of photoreceptor cells with minimal macrophage infiltration. After 3 hour-
continuous light exposure, the rats were allowed to recover for 0，1, 3，6, 12, 24 or 
96 hours in the dark. During this period, the animals were allowed free access to 
food and water. The unexposed control group of eight rats were kept in cyclic light 
for 14 days and put in the dark for 24 hours before euthanasia. All procedures 
involving animals were performed according to the guidelines established in 
Association for Research in Vision and Ophthalmology Resolution for the use of 
animals in research study. 
V.2. Tissue Processing 
V.2.1. Paraffin-embedded tissues 
Four rats from each group were euthanized with carbon dioxide and the eyes 
were enucleated immediately. A 26.5 gauge needle [Precision Glide Needle, 
Singapore] was inserted vertically through the superior comea from the 12-o'clock 
position to mark the superior quadrant of the globe. The left eyes were fixed in 
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Davidson's fixative (32% ethanol, 2.2% neutral buffered formalin and 11% glacial 
acetic acid in distilled water) for 24 hr and the right eyes were fixed in 10% neutral 
buffered formalin for 6 hours at room temperature. The inferior half of the comea 
and the lens were removed after 2 hours offixation. 
Tissue samples were dehydrated and permeated in an automatic tissue 
processor [Citadel 1000，Citadel Tissue Processor, Shandon; Runcom, Cheshire, 
England] using the following program: 70% and 95% ethanol for 30 minutes each, 
absolute ethanol for 1 hour, two changes of absolute ethanol for 1.5 hours each, 
xylene for 1 hour, two changes of xylene for 1.5 hours each, paraffin for 1 hour, two 
changes ofparaffm for 2 hours each with the last change under vacuum. 
The tissue samples were embedded in paraffin [Paraplast Plus Tissue 
Embedding Medium, St. Louis, MO, USA] in a metallic mould for parasaggital 
sectioning. Four-micron paraffin sections were cut with a Rotary Microtome [2035 
Biocut, Leica AG; Nussloch, Germany]. Sections passing through the optic nerves 
from tissues fixed with Davidson's fixative were collected on glass slides 
[Superfrost Plus Treated Microscope Slide, Fisher Scientific, Pittsburg, PA, USA] 
while sections from neutral buffered formalin-fixed tissue were collected on silane 
coated slides [In Situ PCR Glass Slides, Perkin Elmer, Foster City, CA, USA] for in 
situ RT-PCR. 
V.2.2. Epoxy-embedded tissues 
Four rats from each group was euthanized by carbon dioxide and the 
enucleated eyes were fixed in 2.5% glutaraldehyde solution in 0.1 M cacodylate 
buffer at pH 7.4 for two hours at 4 °C. Part of the comea was removed after 2 hours 
of fixation and the remaining part was post-fixed ovemight at 4 °C. After fixation, 
the rat retinas were sampled into four strips: each from the superior, nasal, inferior 
and temporal q u a d r a n t s 4 2 3 . The tissue samples were rinsed by 0.1 M cacodylated 
buffer, pH 7.4 with two changes for 5 minutes each. The tissue samples were then 
post-fixed in 1% osmium tetroxide [Electron Microscopy Sciences; Fort 
Washington, PA, USA] in 0.1 M phosphate buffer, pH 7.4 for one hour at room 
temperature. After washing with three changes of distilled water. The tissue 
samples were dehydrated in graded ethanol from 30 % to absolute ethanol, infiltrated 
with pure propylene oxide for 20 minutes each with two changes, and transferred 
into freshly prepared 1:1 propylene oxide-resin mixture [Embed 812 kit; Specially 
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distilled dodecemyl succinic anhydride (DDSA), nadic methyl anhydride O^MA) 
and 2,4,6-Tri (dimethylaminomethyl)phenol (DMP-30) [Electron Microscopy 
Sciences; Fort Washington, PA, USA] for 1 hour at room temperature, to 1:3 
propylene oxide-resin mixture for 3 hours at room temperature, and to pure resin 
ovemight at room temperature. The tissue samples were embedded in pure resin 
mixture and cured at 6 0 � C for at least 18 hours. 
After trimming, each specimen was sectioned into 1 ^m thick by a Reichert 
Ultracut R [Leica AG; Wien, Austria]. Sections consisting of the pheripheral to 
posterior retina were collected on a glass slide. 
V.3 Cell Culture 
R6 is a line of embryonic fibroblast from rats. M13-8 cell line was 
originated from the R6 and transformed by mutant human p53 gene with (Alanine to 
Valine) mutation at the 138^ codon which corresponds to the Vall35 mutation of 
p53 in mouse. The M13-8 that overexpresses mutant p53 was used as our positive 
controls for p53 and p21 immunohistochemistry. These cell lines were kindly 
provided by Dr Wendy Hsiao from the Department of Biochemistry, The Hong 
Kong University of Sciences and Technologies. Briefly, a vial of frozen cells was 
thawed in a water bath. Cells were collected by spinning the tube at 1000 rpm for 5 
minutes [Centra - CL2, IEC, Needham Heights, MA, USA]. The supernatant was 
discarded and the pelleted cells were resuspended in low glucose Dulbecco's 
Modified Eagle Medium (DMEM), pH 7.3 [GibcoBRL, Grand Island, NY, USA]. 
For immunohistochemical study, approximately 8 x 10^  cells/mm] were transferred 
to the Lab-Tek Chamber Slide pSfalge Nunc, International Naperville, IL, USA] and 
cultured at 37 °C with 5% CO2. After the cells reached confluency, the medium was 
discarded and the chambers were washed with 0.01M PBS, pH7.3. The cells were 
fixed with 10% neutral buffered formalin or Davidson's fixative for 6 hour at room 
temperature. After washing, the slides were air dried and stored at 4 °C. 
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VI. LIGHT MICROSCOPY STUDY 
VI.1. Histopathology 
VL1.1. Toluidine Blue 
Epoxy Sections consisting of the pheripheral to posterior retina were 
collected on a glass slide, heat-dried and stained with 1% filtered toluidine blue for 
about 30 seconds. Finally, the slides were rinsed with water and mounted by 
permount mounting medium. The slides were examined under the microscope for 
studying the histopathological changes. 
VI.1.2. Morphometry of the ONL thickness 
The retinas were collected as mentioned in V.2.1. and stained with 
Haematoxylin & £osin (H&E). To assess the photoreceptor cell loss quantitatively, 
the thickness of the ONL in the superior quadrant of the retina was measured on the 
sections extending from the posterior pole to Ora Serrata under the light microscope 
equipped with Leica Q500MC Image Analysis System [Leica, Cambridge, UK]. 
The results were expressed as average thickness of each group 土 standard derivation 
(S.D.) and the Tukey's Pairwise Multiple Comparison Test were applied to 
determine the differences among different groups. 
VI.2. Terminal Deoxynucleotide Transferase-mediated dUTP-biotin 
Nick End Labeling (TUNEL) 
Apop-Taq in Situ Apoptosis Detection Kits from Oncor [Oncor, 
Gaithersburg, MD, USA] were employed to detect nicked DNA in situ. All 
procedures were according to the standard protocol provided by the manufacturer 
with few modifications. Briefly, the Davidson's-fixed paraffin-embedded retinal 
sections were preheated at 7 0 � C for 20 minutes on the hot-plate, deparaffinized with 
xylene and re-hydrated with graded ethanol. Activity ofthe endogenous peroxidase 
was quenched by incubation with 3% hydrogen peroxide (H2O2) [BDH Lab. 
Supplies，Poole, ITD, England] in methanol for 10 minutes at room temperature. 
The sections were incubated with terminal deoxynucleotide transferase (tdt) and its 
digoxigenin linked dUTP substrate in reaction buffer for 1 hour at 37 °C. The 
reaction was terminated by putting the slides into pre-warmed stop/wash buffer for 
30 minutes at 3 7 � C . After washing, anti-digoxigenin-peroxidase antibody was 
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applied to each section and the sections were incubated for 1 hour at room 
temperature. Positive staining was developed with 0.05% filtered diaminobenzidine 
tetrahydrochloride (DAB) [Sigma Chemicals, St. Louis, MO, USA] in 0.05M Tris 
buffer, pH 7.2, containing 0.03% H2O2. The color development was stopped by 
running tap water and the sections were then dehydrated and mounted with 
Permount Mounting Medium [Toluene Solution, Permount, Fisher Scientific, Fair 
Lawn, NJ, USA]. The dystrophic retinas of Royal College of Surgeon (RCS) rats 
[Animal House of The Chinese University of Hong Kong] at 35 days of age were 
used as positive control424. 
VI.2.1. Morphometry ofTUNEL 
The total numbers of in situ TUNEL-positive cells per retinal section were 
taken under a Diastar Leica microscope [Leica, Germany]. Only those cells in 
which the labeling was confined to the nucleus were counted. Totally stained nuclei 
as well as those with peripheral staining were scored as TUNEL-positive. The total 
length of the outer nuclear layer (ONL) was measured as mentioned earlier in VI.1.2. 
The average number of TUNEL-positive cells per unit length of the retina and their 
standard derivation (S.D.) were plotted. The Studen-Newman-Keuls Methods were 
applied to determine the differences among different groups. 
VI.3. Immunohistochemistry 
VI.3.1. Single-labeling 
Immunoreactivities of p53, p21, bax, c-fos and clusterin were detected by 
standard immunohistochemical methods. The antibodies and their working dilution 
were listed in Table 1. 
TABLE 1. List ofAntibodies 
Antibody Isotype Known Species Reactivity Working Dilution 
- P53 Sheep polyclonal IgG Human, Mouse, Rat 1:500 
- P^j Goat polyclonal IgG Human, Mouse, Rat 1:200 
Bax Rabbit polyclonal IgG Human, Mouse, Rat, 1:40 
Opossum 
g-fos Rabbit polyclonal IgG Human, Mouse, Rat 1:100 
- g ! ^ i n RabbitpolyclonaUgG Rat 1:100 
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VI.3.1.1 Immunolabeling ofp53 protein 
A purified sheep anti-p53 polyclonal antibody Q)53(Ab-7), Oncogene, 
Cambridge, MA, USA] was used in this study. Retinal sections were deparaffmized, 
rehydrated and the antigen was then retrieved by incubating in 10 mM citrate buffer, 
pH 6.0 for 40 minutes at 90 °C. Endogenous peroxidase activity was quenched by 
incubation with 3% hydrogen peroxide (H2O2) in absolute methanol for 10 minutes 
at room temperature. To minimize non-specific bindings, 3% normal rabbit serum 
[Vectastain ABC Kit for sheep IgG, Vector Lab., Burlingame, CA, USA] was 
applied and incubated for 1 hour at room temperature. The sections were then 
incubated with diluted anti-p53 antibody (1:500) in 0.01M PBS, pH 7.3 overnight at 
4 °C. Biotinylated rabbit anti-sheep IgG [Vectastain ABC Kit for sheep IgG] in 
0.01M PBS, pH 7.3 was added and incubated for 1 hour at room temperature and 
followed by incubation with peroxidase-conjugated streptavidin [Vectastain ABC 
Kit for sheep IgG]. Brownish color was developed in 0.05% filtered DAB in 0.05 M 
Tris buffer, pH 7.6 containing 0.03% H2O2. The reaction was stopped by rinsing 
with running tap water and the sections were dehydrated and mounted with 
permount mounting medium. For positive and negative control of p53 
immunohistochemistry, a rat embryonic fibroblasts (M13-8) overexpressing p53 and 
a normal rat embryonic fibroblasts (R6) were used. 
VI.3.1.2. Immunolabeling ofp21 protein 
Purified goat-anti p21 polyclonal IgG [p21(C19), Santa Cruz Biotech.，USA] 
was used in this study. The protocol was similar to the preceding section on p53 
except the working strength of the primary anti-p21 antibody at 1:200 and the 
Vertastain ABC Kit for goat IgG were used. A rat embryonic fibroblasts (M13-8) 
overexpressing p53 and normal rat embryonic fibroblasts were used as our positive 
and negative control respectively. 
VI.3.1.3. Immunolabeling ofbax protein 
Purified rabbit-anti bax polyclonal IgG [bax(Ab-l), Cat# PC66, Oncogene 
Research Product, Cambridge, MA] was used in this study. Procedures similar to an 
immunolabeling of p53 were used with antibody against bax at 1:40 and Vectastain 
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ABC kit for rabbit IgG. A section of seminiferous tubules in rat testis was used as 
our positive c o n t r o P ^ s 
VI.3.1.4. Immunolabeling of c-fos protein 
Purified rabbit-anti c-fos polyclonal IgG [c-fos(AB-2), Calbiochem, 
Cambridge, MA, USA] was used. The dilution of the primary antibody was 1:100 
and a Vectastain ABC Kit for rabbit IgG was used in this study. Procedures similar 
to the immunolabeling of the p53 protein were applied. A section of rat cerebellum 
was used as our positive c o n t r o H ^ e 
VI.3.1.5. Immunolabeling of clusterin protein 
Purified rabbit-anti clusterin polyclonal IgG [Upstate Biotech., Lake Placid, 
NY] was used in this study. Procedures similar to immunolabeling of p53 were 
applied. The working dilution of the primary antibody was 1:100. A section of 
epididymus of rat was used as our positive control427*429 
VI.3.2. Double-labeling 
VI.3.2.1 TUNEL & fluorescent-labding ofp53 
In situ DNA nicks were first detected by TUNEL using the Apop-Taq in situ 
Apoptosis Kit from Oncor with previously described procedure (VI.2.). The primary 
color development was stopped by rinsing with running tap water and the sections 
were stored in 0.01M PBS, pH 7.3 until the second labeling. 
To immunolocalize p53 protein on the same retinal sections，endogenous and 
exogenous peroxidase activity was quenched by 3 % H2O2 in methanol for 5 minutes 
at room temperature. The sections were permeabilized with 0.1% Triton X-100 and 
0.1% sodium citrate in deionized water for 1 hour at 37 °C. Background binding 
was then blocked by 3% normal rabbit serum [Vectastain ABC Kit for sheep IgG]. 
The sections were incubated with diluted sheep anti-p53 polyclonal IgG (1:500) at 4 
C ovemight. Biotinylated rabbit anti-sheep antibody [Vectastain ABC Kit for 
sheep IgG] was applied and incubated for 1 hr at room temperature. Fluorescein-
conjugated streptavidin [Trevigen, Gaithersburg, MD, USA] was added for 30 
minutes at room temperature. After mounting with aqueous mounting medium 
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[Aquamount, Lemer Lab., USA], the retinal sections were examined immediately 
under a Leica DMRB microscope [Postfach, Germany] using the 495 nm filter. 
Micrographs were taken with Kodak film (Kodak TMAX 100). Cautions were taken 
to prevent unnecessary exposure to light after labeling. 
VI.3.2.2. TUNEL & Fluorescent-labding ofp21 
Procedures similar to the preceding section were used. Briefly, DNA nicks 
were firstly detected by TUNEL, then diluted goat anti-p21 polyclonal IgG 
[p21(C19), Santa Cruz Biotech., USA] was applied, followed by biotinylated rabbit 
anti-goat IgG, and incubation with fluorescein-conjugated streptavidin. The sections 
were examined under the microscope and micrographs were taken with Kodak film 
[KodakTAX100]. 
VI.3.3. Grading of Immunoreactivities 
Immunoreactivities (IRs) in the RGCL, INL and ONL were graded by three 
observers including the author, the highest intensity in a series was assigned as 5 and 
the lowest as 1. The percentage of cells stained in that ranks were also recorded. 
The sum of the multiple of the rank and the percentage of cells in that rank in each 
layer gave an estimate of the total immunoreactivities. The scores were reported as 
mean scores 士 standard derivation (S.D.) and Tukey's Pairwise Multiple 
Comparison Tests were applied to determine the differences among different groups. 
VL3.4. Morphometry of c-fos immuno-positive nuclei 
The total numbers of c-fos immuno-positive cells per retinal section were 
counted under a Diastar Leica microscope [Leica, Germany]. Both totally stained 
nuclei as well as those with peripheral staining were scored as c-fos positive. The 
total length of the ONL was measured by an image analyzing system [Leica 
Q500MC, Cambridge, UK]. The number of c-fos immuno-positive cells per unit 
length of the retina was calculated. The results were expressed as mean number of 
immuno-positive nuclei per unit length of the retina 土 S.D. and Pairwise Multiple 
Comparison Tests were applied to determine the differences among different groups. 
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VI.4 . /# i5 i7MRT-PCR 
Solution PCR was performed to test the primers and optimize the annealing 
temperature of the specific primers before performing in situ RT-PCR. 
VI.4.1. Isolation ofretinal DNA 
The RapidPrep Micro Genomic DNA Isolation Kit [Cat# 27-5225-01, 
Pharmacia Biotech.，NY, USA] was used in this study. The kit contained extraction 
buffer, application buffer, wash buffer, elution buffer, and ion-exchange MicroSpin 
columns. All procedures were according to the standard protocol provided by the 
manufacturer. Briefly, a frozen whole rat retina together with vitreous 
(approximately 20 mg) was extracted with 50 |iL extraction buffer in a 1.5 mL 
Eppendorf tube. After homogenization, it was incubated for 30 minutes at 55 °C. 
Eight hundred |iL application buffer was added. The content was mixed and 
allowed to stand for 5 minutes at room temperature. The mixture was then 
centrifuged for 2 minutes at 16,000 xg [Centrifuge 5415C, Gepnifte Sicherhelt, 
Germany]. The supernatant was pipetted into the pre-spun MicroSpin column. The 
column with supporting eppendorf tube was centrifuged for 2 minutes at 735 xg. 
The resin was then washed with 400 ^L wash buffer and the column was centrifuged 
for 2 minutes at 735 xg. The extracted DNA was then eluted by the elution buffer 
with centrifugation for 2 minutes at 735 xg. Three hundred and twenty i^L 
isopropanol [Sigma Chemical Co., St. Louis, MO, USA] was added to 400 i^L of 
the eluted DNA in a clean eppendorf. The mixture was allowed to stand for 10 
minutes at room temperature. DNA was collected by centrifuging for 10 minutes at 
735 xg, resuspended in deionized water, and stored at -20 °C until use. 
VI.4.2. Polymerase chain reaction (PCR) 
The GeneAmp PCR Core Kit [Perkin Elmer,Foster City, CA, USA] which 
contained AmpliTaq DNA polymerase, 10X PCR buffer II，25 mM MgCl2 solution 
and deoxynucleoside triphosphates (dNTPs) was used in this study. The 20 |iL PCR 
master mix was prepared as followed: 2 [xL PCR buffer II, 2.5 mM MgCl2, 200 i^M 
of each dNTP, 0.2 ng DNA template and 0.5 ^M sense and antisense primers. To 
reduce primer dimerization and mis-priming, AmpliTaq DNA polymerase was 
added to a preheated master mix. The GeneAmp PCR System 9600 [Perkin Elmer, 
Foster City, CA, USA] was used in this study. The condition of the PCR was 
programmed as followed: 5 minutes at 95 °C and 40 thermal cycles with each cycle 
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consisted of three temperatures (I) 95 °C for 50 seconds; (II) 55 or 58 °C for 50 
second and (III) 72 °C for 70 seconds. After the thermal cycles, the PCR products 
were extended for additional 10 minutes at 72 °C. The reactions were then stopped 
at 4 °C and the mixtures were stored at -20 °C afterwards. A 1.5% agarose 
[GibcoBRL, Grand Island, NY, USA] gel was used to separate the PCR products by 
DNA electrophoresis that was performed at 80 Volts in IX TBE buffer using a Mini 
Gel System [Submarine Gel System Model EC 370, E-C Apparatus, St. Petersburg, 
FL，USA]. The gel was stained with ethedium bromide [Sigma Chemical Co., St. 
Louis, MO, USA] and the bands were visualized by transillumination with 
ultraviolet light [Foto/PerpI, Fotodyne Incorporated, Hartland, WI, USA]. 
Micrographs were taken with Polaroid 667 film. 
Sequence specific primers for p53 and bax (Table 2) were manufactured by 
Oligos Etc. and Life Technologies respectively. Primers specific to p53 gene were 
designed by Ohgaki (1992) and the primers specific to bax were designed by a 
computer-aided program PRIMER3 v0.2b. The lyophilized primers were 
resuspended in deionize water with a final concentration of 0.1 mM and stored at -20 
°C until use. 
Table 2. List ofPrimers 
Gene 一 Primer Sequences Tm("C) b.p. 
P53 Forward 5’-ACTCAATTTCCCTCAATAAG-3’ ^ T ^ 
Reverse “ 5 ‘ - CAC CAT CAG AGC AAC GCT CA - 3 ’ 
bax Forward “ 5，- CCA AGA AGC TCA GCG AGT GTC TC - 3’ 55 M ^ 
Reverse 5 ’ - AGT TGC CAT CAG CAA ACA TGT CA - 3 ’ 
VI.4.3. in situ reverse- transcriptase(RT)-PCR 
All procedures were according to the standard protocol provided by the 
manufacturerii4. The GeneAmp In Situ PCR Core Kit [Perkin Elmer, Foster City, 
CA，USA], AmpliCover Discs and AmpliCover Clips designed by Perkin Elmer 
[Foster City, CA, USA] were used in this study. Briefly, the retinal sections were 
deparaffinized, dehydrated and air-dried. The sections were digested with freshly 
prepared pepsin solution (20 mg/mL in 0.01N HCl). Genomic DNA was digested 
by RNase-free DNase [Promega, Madison, WI, USA] at 37 °C overnight. After 
washing, Murine Leukemia Virus Reverse Transcriptase (MuLV RT) [Perkin Elmer, 
Foster City, CA, USA] solution was applied to the retinal sections and incubated at 42 Op r ,A ^ ior 30 minutes in the GeneAmp In Situ PCR System 1000 [Perkin Elmer, 
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Foster City, CA, USA]. The RT solution included IX PCR buffer II，5 mM MgCl2, 
1 mM each dNTP, 1 ^M specific antisense primer and 25000 U/mL MuLV RT. 
After synthesizing the first-strand cDNA, in situ PCR was performed by applying 
PCR master mix that consisted of IX PCR buffer II, 4.5 mM MgCl2, 200 ^M each 
dNTP, 10 |LiM digoxigenin-11 -2‘ -deoxy-uridine-5 ‘ -triphosphate (DIG-ll-dUTP) 
(Boehringer Mannheim, Indianapolis, IN, USA), 0.8 ^M each primer and 300 U/mL 
DNA polymerase, in vitro PCR conditions previously described (VI.4.2.) were used. 
Digoxigenin-labeled PCR products were detected by alkaline phosphatase 
conjugated anti-DIG antibody [Boehringer Mannheim, USA] diluted at 1:200 with 
0.1 M Tris-HCl, pH 7.5. The purple precipitate appeared where digoxigenin was 
incorporated into cDNA after incubating with 4-nitro blue tetrazolium chloride/5-
bromo-4-chloro-3-indoyl-phosphate fNBT/BCIP) substrate solution [Liquid 
BCIP/NBT Substrate Kit, Zymed, USA]. 
Similar procedures were applied on two adjacent sections on the same slide 
except omitting the steps of reverse transcriptase (RT) or omitting both the DNase 




Four quadrants of the retinas were examined and the superior and temporal 
quadrants and temporal quadrants showed most severe changes. In addition, the 
tissue damages were most severe in the equatorial region of the retina. For 
convenience and the particular purpose of this study, except the quantitative or semi-
quantitative studies such as morphometry and grading of immunoreactivities, only 
the representative severely damaged areas of the superior retinas were presented 
here. 
VII. LIGHT MICROSCOPY 
VII.1. Histopathology & Morphometry 
VII.1.1. Histopathology 
Immediately after photic injury, some horizontal cells appeared edematous 
(Figure 2B). The outer plexiform layer (OPL) was vacuolated and mild edema was 
noted in the inner part of the outer nuclear layer (ONL). Vacuolation was also noted 
in the inner segments (IS) and outer segments (OS). Dense granules appeared in the 
subretinal space and the retinal pigment epithelium (RPE). These changes continued 
at 1 hour (2C). At 3 hours after light exposure (Figure 2D), the edema of some 
horizontal cells and the OPL appeared to subside. Densified and shrunken nuclei 
were observed in the ONL and the whole ONL was edematous. The OS remained 
vacuolated and disorganized when compared to the normal retina (Figure 2A). 
Dense granules were persisted in the subretinal space and the RPE. These changes 
except the granulation which subsided, progressed through 6 and 12 hours with 
increasing number of densified and shrunken nuclei in the ONL. At 24 hours 
(Figure 2G), vacuolation of the OPL and edema of the ONL subsided. The ONL 
was focally thinned with 8 -10 nuclei per column compared to 10-12 ofthe normal. 
A few densified nuclei remained. The OS was vacuolated and shortened. 
Macrophage infiltration was not noted. At 96 hours (Figure 2H), focal vacuolation 
ofthe OPL remained. The ONL was disorganized with markedly loss of nuclei and 




Figure 2: Histopathologic features of the superior retinas at various time 
after light exposure. (A) Unexposed control: Note the well-
organized outer nuclear layer (ONL) with 10-12 photoreceptor nuclei 
per column. The inner (IS) and outer segments (OS) were well-
aligned. (B): Immediately after light exposure: Some horizontal 
cells appeared edematous (arrow). The outer plexiform layer (OPL) 
was vacuolated. The inner half of the ONL showed mild edema. 
Mild vacuolation was also noted in the IS and outer zone of the OS 
(arrowheads). Dense granules were noted in the retinal pigment 
epithelium (RPE) and subretinal space (asterisks). (C) At 1 hour 
after light exposure: Edema of the horizontal cells subsided. The 
OPL remained vacuolated. The edematous ONL showed scattered 
densified and shrunken nuclei (arrows). The IS and OS were 
moderately vacuolated and mildly disorganized (arrowheads). Many 
dense granules persisted in the IS, OS, subretinal space and RPE. (D) 
At 3 hours after light exposure: The vacuolation of the OPL 
subsided. The ONL showed increased number of densified and 
shrunken nuclei (arrows). The OS remained mildly vacuolated and 
disorganized (arrowhead). Dense granules remained in the subretinal 
space and RPE. IPL: i n n e r plexiform layer (Toluidine Blue, X400) 
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Figure 2: Continued. 
(E) At 6 hours after light exposure: The OPL remained vacuolated. 
Densified nuclei in the ONL persisted. The OS vacuolated at the 
outer zone (arrows). Dense granules (arrowhead) persisted in the 
subretinal space and the RPE. (F) At 12 hours after light exposure: 
The OPL remained vacuolated. Densified nuclei persisted in the 
ONL (arrows) and some photoreceptor cells in the outer zone of the 
ONL showed edema (asterisks). Vacuolation in the OS persisted 
(arrowheads). Granulation in the outer retina subsided. (G) At 24 
hours after light exposure: Vacuolation of the OPL subsided. 
Thinning of the ONL with 8-10 nuclei per column remained and a 
few densified nuclei (arrows) were noted. The OS remained 
vacuolated (arrowhead) and appeared shortened. The RPE was 
unremarkable. (H) At 96 hours after light exposure: Focal 
vacuolation of the OPL subsided. The ONL was disorganized and 
showed marked loss of nuclei focally with scattered densified or 
shrunken nuclei (arrows). The IS and OS were disrupted and focally 
lost. The RPE was heavily granulated and disrupted focally 
(arrowhead). (Toluidine Blue, X400) 
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VII.1.2. Morphometry ofthe ONL thickness 
Figure 3 showed the average thickness of the ONL of the superior quadrant 
gradually decreased over time after light exposure. Normal control retinas showed 
an average thickness of 40.67 土 5.93 ^m. There was no statistically significant 
change in the thickness of the ONL up to 24 hours after light exposure. However, 
there was a slight insignificant drop in the ONL thickness at 6 hours (33.75 士 3.6 
|im). At 96 hours, a statistically significant drop of the average ONL thickness was 
noted when compared with 24 hours (24.83 土 2.67 Vs 36.08 土 3.72 i^m) and the 
normal unexposed retinas (24.83 士 2.67 Vs 40.67 土 5.93 ^im). 
VII.2. DNA Nicks Detection 
VII.2.1./«w7ttTUNEL 
The positive control (Figure 4) showed the typical ring-like pattem of 
labeling of the nuclei in the ONL of retinal dystrophic Royal College of Surgeons 
(RCS) rat retina at 35-days of age. The normal unexposed rat retina showed no 
TUNEL-positive nuclei (Figure 5A). Immediately after light exposure, TUNEL-
positive nuclei (arrows) were present in the inner part of the ONL (Figure 5B). The 
number of TUNEL-positive nuclei increased gradually between 0 to 12 hours 
(Figures 5C-F) but they remained mostly in the inner part of the ONL. At 24 hours 
(Figure 5G), the number of TUNEL-positive nuclei increased sharply and they were 
no longer restricted in the inner half of the ONL. At 96 hours (Figure 5H), the ring-
like pattem of labeling decreased and a few densely labeled nuclei were also present. 
The inner retina showed no significant labeling throughout the observation period. 
VII.2.2. Morphometry ofTUNEL 
Figure 6 showed there is a time dependent increase in the number of 
TUNEL-positive nuclei in the superior quadrant of the retina starting immediately 
after light exposure (0.6 土 0.12 positive nuclei/mm). All values from 0 to 96 hours 
were significantly different from the normal, and all values from 6 to 96 hours were 
statistically significantly different from their preceding groups such as the 6 hour 
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Figure 3: Morphometry of the outer nuclear layer (ONL) thickness of the 
superior retinas at various time after light exposure. Note the 
statistically significant decrease of the ONL thickness at 24 and 96 hr 
after light exposure. * P < 0.05 when compared with normal; # P < 
0.05 when compared with their respectively preceding groups 
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Figure 4: Positive control for TUNEL using the retinal dystrophic retina of 
a 35-day old Royal College of Surgeon (RCS) rat. Note the 
presence of TUNEL-positive nuclei (arrows) with ring-like pattem in 
the outer nuclear layer (ONL) ofa 35-days old RCS rat. (DAB, X400) 
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Figure 5: TUNEL of the superior retinas at various time after light 
exposure. (A) Normal unexposed retina: No TUNEL-positive 
nucleus in the retina. (B) 0; (C) 1; (D) 3; (E) 6; and (F) 12; and (G) 
24 hours: Note the progressive appearance of dense pheripheral 
nuclear staining with ring-like pattem (arrows) especially in the inner 
half of the outer nuclear layer (ONL) at the beginning with maximal 
labeling at 24 hours. (H) 96 hours: There was a significant loss of 
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Figure 5: Continued. 
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Figure 6: Morphometry of in situ TUNEL-positive nuclei in the superior 
retinas. Note the significant increase of the TUNEL-positive nuclei 
at all time points after light exposure. * P < 0.05 when compared 
with normal; # P < 0.05 when compared with their respectively 




VII.3.1. Immunohistochemistry ofp53 
The positive control showed strong p53 IRs in the nuclei of embryonic 
fibroblasts that overexpressed wild type p53 protein (Figure 7A), while normal 
embryonic fibroblasts showed low basal level of p53 IRs (Figure 7B). The superior 
quadrant of the normal dark-adapted rat retina showed stronger immunoreactivities 
(IRs) of p53 at the ONL when compared with those of the INL and RGCL (Figure 
8A). Immediately after photic injury, there was a generalized increase of the IRs in 
the ONL with scattered nuclei showing mild increase while other layers appeared 
unchanged (Figure 8B). At 1 hour, Miiller cells-like nuclei in the INL showed 
increased IRs of p53 and elevated levels of p53 in the ONL persisted in scattered 
nuclei (Figure 8C). At 3 hours (Figure 8D), the RGCL remained unchanged. The 
IRs of the nuclei in the middle part of the INL decreased while IRs in the ONL 
continued to increase. Granules with strong IRs were noted in the outer zone of the 
IS. Between 6 (Figure 8E) and 12 hours (Figure 8F), the IRs in the RGCL and INL 
remained unchanged. The IRs in the ONL diminished but scattered nuclei continued 
to show strong IRs. A thread-like staining was noted in the IS and OS focally. At 
24 hours (Figure 8G), the IRs in the RGCL and INL subsided. Generalized decrease 
of p53 IRs was noted while isolated nuclei showing strong IRs. Scattered granules 
with strong IRs were noted in the IS and OS. At 96 hours (Figure 8H), recovery of 
p53 IRs in scattered nuclei were noted. 
VII.3.2. Grading of p53 immunoreactivities 
Figure 9 showed the overall grading of p53 IRs at the RGCL, INL and ONL 
of the superior retinas at various times after light exposure. The ONL showed the 
highest IRs scores when compared with those of the RGCL and INL. There was no 
significant difference in IRs scores of p53 among all time points except at 24 hours 
showing a significant decrease ofIRs in the INL when compared with normal. 
VII.3.3. p53 in situ RT-PCR 
PCR products of the p53 primers were shown in Figure 10. Note the primers 
of p53 amplified a band of approximately 180 b.p. (Lane 1 & 2) corresponding to 
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Figure 7: Positive control for p53 immunohistochemistry using cultured 
embryonic fibroblast (M13-8) from the rat. (A) Transfected rat 
embryonic fibroblast (M13-8) overexpressing p53: The nuclei 
showed strong p53 IRs. (B) Normal rat embryonic fibroblast (R6): 
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Figure 8: Immunohistochemistry of p53 in the superior retinas at various 
time after light exposure: (A) Normal unexposed retina: Retinal 
ganglion cell layer (RGCL) and the inner nuclear layer (INL) showed 
mild immunoreactivities (IRs). Note moderate IRs of p53 in the 
nuclei (arrows) ofthe outer nuclear layer (ONL). The inner segments 
(IS) showed mild IRs. The outer segment (OS) and retinal pigment 
epithelium (RPE) showed no IRs. (B) 0 hour: IRs of the RGCL and 
INL remained unchanged. There was mild and generalized increase 
of p53 IRs in the ONL with scattered nuclei (arrows) showing more 
increase. The IS also showed increased p53 IRs focally (arrowhead). 
(C) 1 hour: The RGCL was unremarkable. Isolated nuclei 
(arrowhead) in the middle of the INL showed moderate IRs. The 
increase in IRs in the ONL persisted with scattered nuclei showing 
more IRs (arrows). (D) 3 hours: The RGCL remained unchanged. 
The IRs of the nuclei (arrow) in the middle of the INL decreased 
while IRs in the ONL continued to increase. Strong IRs were noted in 









































































Figure 8: Continued. 
(E) 6 hours and (F) 12 hours: IRs in the RGCL and INL remained 
unchanged. IRs in the ONL diminished but scattered nuclei 
continued to show strong IRs (arrows). A thread-like staining was 
noted in the IS and OS focally (arrowheads). (G) 24 hours: IRs in 
the RGCL and INL subsided. Note the generalized decrease of p53 
IRs in the ONL with isolated photoreceptor nuclei showing strong 
IRs (arrows). Scattered strong IRs was noted in the IS (arrowhead). 
(H) 96 hours: Note the recovery of p53 IRs in scattered nuclei 
(arrows) ofthe ONL. (DAB, X400) 
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Figure 9: Grading of p53 immunoreactivities (IRs) in the superior retinas 
at various time after light exposure. Note the significant decrease 
in p53 IR of the JNL at 24 hours. RGCL: retinal ganglion cell layer; 
INL: inner nuclear layer; ONL: outer nuclear layer. * P < 0.05 when 
compared with normal [Tukey's Pairwise Multiple Comparison Test]. 
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The p53 specific DNA fragment. The positive control for p53 in situ RT-PCR using 
cultured embryonic fibroblasts from rat showed strong p53 reaction signals (RSs) 
(Figure 11). In the normal rat retina, the ONL showed moderate expression of p53 
mRNA when compared with the INL and RGCL (Figure 12A). Immediately after 
photic injury, there was a decrease in p53 mRNA expression in the ONL and FNL 
(Figure 12B). At 1 hour, more than half of the nuclei at the ONL showed increased 
p53 mRNA expression. The INL and RGCL both showed relatively weak 
expression of p53 mRNA (Figure 12C). High levels of p53 mRNA expression were 
detected in most nuclei of the ONL at 3 hours. The INL and RGCL also showed 
elevated level expression of p53 mRNA (Figure 12D). However, the majority of 
nuclei in the inner half of the ONL showed overall down-regulation of p53 mRNA 
expression at 6 hours. The INL show relatively low expression of p53 mRNA and 
the RGCL showed undetectable mRNA expression (Figure 12E). At 12 hours, p53 
mRNA in isolated nuclei in the ONL was further suppressed. Both the INL and 
RGCL showed very low level of mRNA expression (Figure 12F). At 24 hours, only 
a few nuclei of the ONL showed p53 mRNA expression (Figure 12G). At 96 hours, 
strong expression of p53 mRNA was detected in scattered nuclei of the ONL (Figure 
12H). 
VII.3.4. Double-labeling ofp53 with in situ TUNEL 
The positive control using cultured embryonic fibroblast from rat 
overexpressing p53 showed most nuclei of fibroblasts with p53 IRs (Figure 13A) 
and concomitant positive TUNEL (Figure 13B). With a fluorescent tag, the normal 
retina showed strong p53 IRs in the ONL and OS (Figure 14A) but no TUNEL-
positive nuclei (Figure 14B). Immediately after photic injury, isolated nuclei in the 
ONL showed nuclei with absence of p53 IRs (Figure 14C) but positive TUNEL 
(Figure 14D). However, some p53 immuno-negative nuclei were not TUNEL-
positive nuclei. This phenomenon could also be observed at later time point such as 
at 6 and 12 hours. At 6 hours, there was a generalized decrease in p53 IRs in the 
ONL with scattered nuclei of the ONL showing no IRs (Figure 14E), some ofwhich 
were also TUNEL-positive (Figure 14F). At 12 hours, p53 IRs recovered in the 
ONL. However, scattered nuclei remained p53 negative (Figure 14G) with some of 
them also TUNEL-positive (Figure 14H). 
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Figure 10: Electrophoretic analysis of PCR products of p53 and bax 
primers. Lane M: multiples of 100 b.p. DNA marker; Lanes 1 and 
2: PCR product of p53 primers showing a single band atl80 b.p. 
corresponding to a p53 specific product; Lanes 3 and 4: PCR 
product of bax primers showing a single band at 146 b.p. 
corresponding to a bax specific product. (Ethedium Bromide, XI) 
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Figure 11: Positive control for in situ RT-PCR of p53 using cultured 
embryonic fibroblast (M13-8) from the rat. (A) Transfected rat 
embryonic fibroblasts (M13-8) overexpressing p53: Note the 
strong reaction signal (RS) in the fibroblasts. (B) Normal rat 
embryonic fibroblasts (R6): The fibroblasts showed weak RS of 
p53. (DAB, X400) 
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Figure 12: In situ RT-PCR of p53 in the superior retinas at various time 
after light exposure. (A) Normal unexposed retina: Note the 
absence of the reaction signal (RS) of in situ RT-PCR, in the retinal 
ganglion cell layer (RGCL). The inner nuclear layer (INL) showed 
mild RS while the outer nuclear layer (ONL) showed moderate RS. 
(B) 0 hour: The RS of the RGCL remained unchanged and the RS in 
the INL decreased. The RS ofp53 persisted in the ONL (C) 1 hour: 
Both the RGCL and INL remained unchanged. The ONL showed 
moderate increase of p53 RS in the ONL with some nuclei (arrows) 
showing more RS. (D) 3 hours: There was a generalized increase of 
p53 RS in the RGCL, INL and ONL. Note some nuclei in the ONL 
showed more RS (arrows). (NBT/BCIP, X400) 
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Figure 12: Continued. 
(E) 6 hours: The RS in both the RGCL and INL subsided. Note 
some nuclei in the ONL showed a decrease of RS in the ONL focally 
while neighboring nuclei remained with strong RS (arrows). (F) 12 
hours: RSs in the RGCL and INL continued to drop, but scattered 
nuclei in the ONL showed moderate RS (arrows). (G) 24 hours: 
Both the RGCL and INL were unremarkable, and only a few 
scattered nuclei in the ONL showed RS (arrows). (H) 96 hours: The 
RGCL，INL and ONL showed moderate RS with scattered 




Figure 13: Positive control for fluorescent-immunohistochemistry of p53 
and TUNEL using cultured embryonic fibroblast (M13-8) from 
the rat. (A) p53 labeling and (B) TUNEL: Note strong p53 
immunoreactivities (IRs) in the fibroblasts (arrows in A) and some of 
these cells were also TUNEL-positive (arrowhead in B). (DAB, 
X400) 
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Figure 14: Fluorescent-immunohistochemistry of p53 and TUNEL in the 
superior retinas at various time after light exposure. (A) p53 
fluorescent immunohistochemistry and (B) TUNEL of normal 
unexposed retinas: (A) Scattered nuclei in the inner nuclear layer 
(INL) showed mild labeling. Note strong p53 immunoreactivities 
(IRs) in the photoreceptor nuclei of the outer nuclear layer (ONL) and 
the outer segment (OS) (A) but no TUNEL-positive nuclei (B). (C) 
p53 fluorescent immunohistochemistry and (D) TUNEL of 
superior retina at 0 hour: (C) The IRs in the INL, ONL and OS 
persisted with scattered while nuclei in the ONL showed loss of p53 
IRs (arrows in C), some of which were also TUNEL-positive 
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Figure 14: Continued. 
(E) p53 fluorescent immunohistochemistry and (F) TUNEL of 
superior retina at 6 hours: (E) Note the decrease in p53 IRs in the 
INL and ONL. Many nuclei lost p53 IRs (arrows in E) but were 
TUNEL-positive (arrowheads in F). (G) p53 fluorescent 
immunohistochemistry and (H) TUNEL of superior retina at 12 
hours: Note the recovery of p53 IRs in the INL and ONL. Almost 
all immuno-negative nuclei (arrows in G) were TUNEL-positive 
(arrowheads in H). (Fluorescein-tag/DAB, X400) 
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VII.4. p21 
VII.4.1. Immunohistochemistry of p21 
The positive control showed strong p21 IRs in the transfected embryonic 
fibroblast (M13-8) overexpressing p53 (Figure 15A) while normal embryonic 
fibroblast (R6) showed p21 IRs only in a mitotic cell (Figure 15B). The normal rat 
retina showed mild p21 IRs in some nuclei ofthe RGCL, all nuclei at the ESfL while 
isolated nuclei showed moderate IRs in the ONL (Figure 16A). Immediately and up 
to 3 hours after photic injury, p21 IRs increased in isolated nuclei in the ONL while 
other layers appeared unremarkable (Figures 16B-D). At 6 hours, there was a 
noticeable decreased in p21 IRs in the ONL (Figure 16E) and this trend continued 
until 96 hours (Figures 16F-H) when p21 IRs at the ONL recovered with a scattered 
nuclei showing a ring-like pattern. 
VII.4.2. Grading of p21 immunoreactivities 
Figure 17 showed the overall grading ofp21 IRs at the RGCL, INL and ONL 
of the superior retinas at various times after light exposure. In the normal control 
retina, IRs of p21 was highest in the ONL. After the light exposure, there was no 
noticeable change in the overall IRs of p21 in the RGCL as well as the JNL. 
Although the ONL showed no statistically significant differences between normal 
and experimental groups from 0 to 12 hours, it appeared that the p21 IRs in the ONL 
showed a transient and slight increase at 3 and 6 hours after light exposure. At 24 
hours, statistically significant decrease was noted. 
VII.4.3. Double-labeling ofp21 with in situ TUNEL 
The positive control using cultured embryonic fibroblasts from rat showed 
moderate p21 IRs in rat embryonic fibroblast (M13-8) overexpressing p53 (Figure 
18A). The highest IRs was noted especially in mitotic cells but no TUNEL-positive 
nuclei were noted correspondingly (Figure 18B). With a fluorescent tag, the normal 
rat retina showed moderate to strong p21 IRs in the nerve fiber layer (N¥L\ inner 
(IPL) and outer plexiform layers (OPL), inner (IS) and outer segments (OS) but no 
TUNEL-positive nuclei (Figures 19A and B). Immediately after photic injury, the 
NFL, IPL，OPL, IS and OS retained their strong p21 IRs (Figure 19C) but no 
TUNEL-positive nuclei were observed (Figure 19D). At 24 and 96 hours, some 
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Figure 15: Positive control for p21 immunohistochemistry using cultured 
embryonic fibroblast (M13-8) from the rat. (A) Transfected 
embryonic fibroblast (M13-8) overexpressing p53: Note moderate 
immunoreactivities (IRs) of p21 in most of the nuclei. (B) Normal 
embryonic fibroblast (R6): Only mild p21 IRs was noted in a 
mitotic fibroblast (arrow). (DAB, X400) 
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Figure 16: Immunohistochemistry of p21 in the superior retinas at various 
time after light exposure. (A) Normal unexposed retina: The 
retinal ganglion cell layer (RGCL), the inner nuclear layer (INL) and 
the outer nuclear layer (ONL) showed mild immunoreactivities (IRs). 
Isolated nuclei (arrows) in the outer nuclear layer (ONL) showed 
moderate IRs. (B) 0; (C) 1; and (D) 3 hours: The IRs ofthe RGCL 
and rNL remained unchanged, but the ONL showed progressive 
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Figure 16: Continued. 
(E) 6; (F) 12; and (G) 24 hours: The RGCL and INL were 
unremarkable. There was a progressive decrease in the number of 
nuclei with p21 IRs in the ONL (arrows). (H) 96 hours: There was a 
recovery of p21 IRs in scattered nuclei in both the INL and ONL 
(arrows). Some nuclei in the ONL showed a pheripheral nuclear 
staining (arrowheads). (DAB, X400) 
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Figure 17: Grading of p21 immunoreactivities (IRs) in the superior retinas 
at various time after light exposure. Note a significant drop in IR 
of the 1NL and ONL at 24 hours post exposure. RGCL: retinal 
ganglion cell layer; 1NL: inner nuclear layer; ONL: outer nuclear 
layer. * P < 0.05 when compared with normal. [Tukey's Pairwise 
Multiple Comparison Test]. 
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Figure 18: Positive control for fluorescent-immunohistochemistry of p21 
and TUNEL using cultured embryonic fibroblast (M13-8) from 
the rat. (A) p21 labeling and (B) TUNEL in transfected rat 
embryonic fibroblasts (M13-8) overexpressing p53: Fibroblasts 
showed strong p21 immunoreactivities (IRs) in mitotic cells (arrows 
in A) and mild IRs in non-mitotic cells (arrowheads in A). No 
TUNEL-positive nuclei were noted (B). (Fluorescein-tag/DAB, 
X400) 
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nuclei in the ONL showed p21 IRs with a ring-like pattern (Figures 19E and G) and 
TUNEL concomitantly (Figures 19F and H). 
VII.5. bax 
VII.5.1. Immunohistochemistry ofbax protein 
The positive control with primary spermatozoa of the rat testis showed 
moderate bax IRs (Figure 20). In normal rat retina only scattered nuclei ofthe ONL 
showed mild bax (Figure 21A). Immediately after light exposure and up to 6 hours, 
bax IRs showed transient increase in scattered nuclei of the ONL (Figures 21B-E). 
At 12 hours (Figure 21F), the bax IRs decreased and returned to its normal 
unexposed level. At 24 and 96 hours (Figures 21G and H), low levels of bax IRs 
remained in the ONL. 
VII.5.2. Grading of bax immunoreactivities 
Figure 22 showed the overall grading ofbax IRs at the RGCL, INL and ONL ofthe 
rat superior retina at various time after light exposure. In the RGCL, it showed a 
transient decrease at 1 hour after light exposure, a recovery and a second decrease at 
12 hours. The change of IRs in the INL was unremarkable. There was no 
significant changes in the scores of IRs in the ONL while the grading showed a 
slightly increase form 0 to 6 hours and a decrease at 12 hours. This low IRs scores 
maintained up to 96 hours. However, these changes were not statistically 
significant. 
VII.5.3. bax in situ RT-PCR 
PCR product of the bax primers was shown in Figure 10. A band of 
approximately 146 b.p. was noted in lane 3 & 4 corresponding to the specific DNA 
fragment of bax gene. In the normal rat retina, the outer half of the INL, the whole 
OPL and the IS showed relatively high expression of bax mRNA. Some isolated 
nuclei in the ONL and RGCL also showed the presence ofbax mRNA (Figure 23A). 
Immediately after photic injury, the bax mRNA was down-regulated in the RGCL, 
INL and IS. The ONL remained unchanged (Figure 23B). At 1 hour, bax mRNA 
was up-regulated in the RGCL, INL and especially in the ONL (Figure 23C). At 3 
hours, the expression of bax mRNA remained unchanged in the RGCL and INL 
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Figure 19: FIuorescent-immunohistochemistry of p21 and TUNEL in the 
superior retinas at various time after light exposure. (A) p21 
fluorescent immunohistochemistry and (B) TUNEL of normal 
unexposed retina: Note mild p21 immunoreactivities (IRs) in the 
inner (IPL) and outer plexiform layer as well as strong IRs in the 
inner (IS) and outer segments (OS) (A) but no TUNEL-positive 
nuclei (B). (C) p21 fluorescent immunohistochemistry and ⑴） 
TUNEL of superior retina at 0 hour: The IPL, OPL and OS 
retained the strong IRs for p21 and scattered nuclei or Mtiller cell 
processes (arrows in C) in the inner nuclear layer (INL) and outer 
nuclear layer (ONL) showed increase of p21 IRs but no TUNEL-




















Figure 19: Continued. 
(E) p21 fluorescent immunohistochemistry and (F) TUNEL of 
superior retina at 24 hours: Strong IRs remained in the IPL, OPL, 
IS and OS. Note scattered nuclei in the ONL showed moderate IRs 
with pheripheral nuclear staining (arrows in E) which were also 
TUNEL-positive nuclei (arrowheads in F). (G) p21 fluorescent 
immunohistochemistry and (H) TUNEL of superior retina at 96 
hours: The IPL, OPL and OS remained unchanged in IRs. The INL 
and ONL showed an increase in p21 IRs. Pheripheral nuclear staining 
was noted in some nuclei of the ONL (arrows in G) that were also 
TUNEL-positive (arrowheads in H). (Fluorescein-tag/DAB, X400) 
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Figure 20: Positive control for bax immunohistochemistry using the testis 
from the Lewis albino rat. Note the moderate immunoreactivities 
(IRs) of bax in primary spermatocyte nuclei (arrows) in the 
seminiferous tubules of an adult rat testis. (DAB, X400) 
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Figure 21: Immunohistochemistry of bax in the superior retinas at various 
time after light exposure. (A) Normal unexposed retina: 
Immunoreactivities (IRs) of bax was undetectable in the retinal 
ganglion cell layer (RGCL). The inner nuclear layer (INL) and outer 
nuclear layer (ONL) showed very mild IRs while scattered 
photoreceptor nuclei showed moderate bax IRs (arrows). (B) 0; (C) 
1； and (D) 3 hours: The RGCL and INL remained unchanged. 
There was a progressive increase in the number of nuclei with 
moderate bax IRs in the ONL (arrows). The changes of IRs above 
was not local but throughout the whole retina. (DAB, X400) 
92 
E “ [ i 
•久,•；-RGCL . # 
‘ .'.-
’‘ . . . . ' " . . • » � • 
.:•' ^ ‘ '• 
- ' . . . ‘ ’ ' • • : � • ^ • . • • • ‘ 
^ ' , ‘ “ . . . � - : " . - -• ’ : . - H .• ."‘ ；<^-:、愈厂.‘ .r- :'x." 
U'-. •«> I 
：. - .<^ ;.;绅-厂-?卢< > V 'T ^ . ¢-、 、 ^ '二�- . ^ . 
I N L ^〉,： 1 ..^  • '\^^' - . " ? � / : ^ 4 r : / / • • k _ m ^ o^ • . * • .. ^  \ X ONL/ f •:• ” . , 
•：.-：-' : " : r i O / 
RPE • 
G H 
？ / / , 
、八 /‘ •/ 
一 ‘ 知 ^ ^ 
Figure 21: Continued. 
(E) 6 hours: IRs of bax in the RGCL and INL remained unchanged. 
There was a continued increase in the number of nuclei with 
moderate IRs in the ONL (arrows). (F) 12; (G) 24; and ¢1) 96 
hours: The RGCL and INL were unremarkable. There was a gradual 
decrease in the number of nuclei with moderate IRs in the ONL 
(arrows). (DAB, X400) 
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Figure 22: Grading of bax immunoreactivities (IRs) in the superior retinas 
at various time after light exposure. Note significant differences in 
IRs of the RGCL at 1 and 12 hours post injury and an apparent 
decrease in the ONL at 12-96 hours. RGCL: retinal ganglion cell 
layer; I N L : inner nuclear layer; ONL: outer nuclear layer. * P < 0.05 
when compared with normal. [Tukey's Pairwise Multiple 
Comparison Test]. 
95 
while the ONL showed down-regulation of bax mRNA (Figure 23D). At 6 hours, 
the ONL showed decreased bax mRNA expression but still remained a relatively 
high expression of mRNA when compared with the RGCL and the INL (Figure 
23E). At 12 hours, the ONL showed down-regulation of bax mRNA while the 
RGCL and INL showed increased bax mRNA (Figure 23F). At 24 hours, the 
expression of the bax mRNA remained in the RGCL and INL and scattered nuclei in 
the ONL showed bax mRNA expression (Figure 23G). At 96 hours, the RGCL and 
INL showed decrease of bax mRNA expression (Figure 23H) while scattered nuclei 
in the ONL showing relatively high mRNA expression. 
VII.6. c_fos 
VII.6.1. Immunohistochemistry of c-fos protein 
The positive control with Purkinje cell from rat cerebellum showed positive 
labeling (Figure 24). The normal rat retina showed relatively moderate c-fos IRs in 
the ONL and some scattered nuclei in the INL (Figure 25A). Immediately after light 
exposure, increased c-fos IRs was noted in scattered photoreceptor nuclei while 
other layers remained unchanged (Figure 25B). At 1 (Figure 25C) and 3 hours 
(Figure 25D) after light exposure, the overall IRs of the ONL increased and the 
number of nuclei with moderated IRs increased in the ONL. Other layers remained 
unchanged. At 6 hours (Figure 25E), a mixture of various shapes of immuno-
positive nuclei were noted mainly in the inner part of the ONL. Other layers 
remained unremarkable. At 12 and 24 hours (Figures 25F and G), the number of c-
fos immuno-positive nuclei increased and they spread to the outer part of the ONL. 
At 96 hours, the number of c-fos immuno-positive nuclei decreased in the ONL. 
The IRs in the RGCL and INL remained low (Figure 25H). 
VII.6.2. Morphometry of c-fos immuno-positive nuclei and TUNEL 
In the superior retina, there was a time dependent and concomitant increase 
from 0 to 24 hours after exposure and decrease at 96 hours in the numbers of c-fos 
immuno-positive nuclei with the number of TUNEL-positive nuclei (Figure 26). At 
12 hours, the increase in the number of c-fos positive nuclei was statistically 
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Figure 23: In situ RT-PCR of bax in the superior retinas at various time 
after light exposure. (A) Normal unexposed retina: Note the weak 
reaction signal (RS) of in situ RT-PCR in the retinal ganglion cell 
layer (RGCL) and the inner part of the inner nuclear layer (ES[L). 
Moderate RS was noted in the outer part of the INL, the outer 
plexiform layer (OPL) and isolated photoreceptor nuclei (arrows). 
Mild RS was also noted in some of the inner segments (IS). (B) 0 
hours: Only scattered nuclei in the ONL showed moderate RS 
(arrows). RS in other layers subsided. (C) 1 hours: There was a 
mild increase of bax RS in the RGCL and INL and noticeable 
increase in the photoreceptor nuclei (arrows). (D) 3 hours: The 
RGCL showed increased RS while the INL remained unchanged. 
There was a significant decrease in the number of nuclei with bax RS 
in the ONL (arrows). The changes of RS above was not local but 
throughout the whole retina. (NBT/BCIP, X400) 
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Figure 23. Continued. 
(E) 6 hours: The RS in the RGCL and INL subsided. Scattered 
nuclei in the ONL showed mild RS (arrows). (F) 12 hours: RS 
reappeared in the RGCL and INL while the changes in the ONL was 
unremarkable. (G) 24 hours: The RGCL and INL continued to 
increase in bax RS. A few photoreceptor nuclei remained moderately 
positive (arrows). (H) 96 hours: The RS in the RGCL and ^ L 
subsided and a few photoreceptor nuclei showed moderate RS 
(arrows). (NBT/BCIP, X400) 
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Figure 24: Positive control for c-fos immunohistochemistry using the 
cerebellum from the Lewis albino rat. Note the moderate staining 
in the cytoplasm of the purkinje cells (arrows). (DAB, X400) 
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Figure 25: Immunohistochemistry of c-fos in the superior retinas at various 
time after light exposure. (A) Normal unexposed retina: The 
retinal ganglion cell layer (RGCL) and the inner nuclear layer (INL) 
showed mild c-fos immunoreactivities (IRs) while the outer nuclear 
layer (ONL) showed moderate IRs. (B) 0 hour: The RGCL and the 
INL remained unchanged. A few isolated photoreceptor nuclei 
showed strong c-fos IRs (arrow). (C) 1; and (D) 3 hours: The 
RGCL and the INL were unremarkable. There was a noticeable 
increase of IRs in the inner half of the ONL. Note some nuclei 
showed intense pheripheral nuclear staining (arrowheads) while 
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Figure 25: Continued. 
(E) 6; (F) 12; and (G) 24 hours: The RGCL and the 肌 showed 
mild IRs. The number of c-fos immuno-positive nuclei in the ONL 
increased. The immuno-positive nuclei showed either intense 
pheripheral nuclear staining (arrowheads) or whole nuclear staining 
(arrows). Irregularly shaped nuclei with c-fos IRs were also noted 
(asterisks). (H) 96 hours: The IRs of c-fos in the RGCL and JNL 
remained unchanged. There was a significant decrease in the number 
of c-fos immuno-positive nuclei in the ONL (arrow). (DAB, X400) 
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Figure 26: Morphometry of c-fos immuno-positive and TUNEL-positive 
nuclei in the superior quadrant of separate retinas at various 
time after light exposure. Note that the numbers of c-fos immuno-
positive nuclei parallel those of positive TUNEL showing a time-
dependent increase after light exposure with maximal values at 24 
hours. * P < 0.05 when compared with normal. [All pairwise 
multiple comparison procedures (Student-Newman-Keuls Method)]. 
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VII.7. Clusterin 
VII.7.1. Immunohistochemistry of clusterin protein 
Positive control using rat prostate showed moderate IRs in the apical area of the 
luminal epithelium (Figure 27). The normal rat retina showed low clusterin IRs in 
the RGCL, INL and ONL. Only isolated nuclei in the outermost of the INL showed 
moderate clusterin IRs (Figure 28A). Immediately (Figure 28B) and 1 hours (Figure 
28C) after light exposure, there was a generalized increase of clusterin IRs in the 
ONL while other layers remained unremarkable. At 3 hours, there was generalized 
increase in IRs in the INL and the ONL and an increase in the number of moderately 
positive nuclei in the ONL (Figure 28D). At 6 hours, the clusterin IRs in the INL 
and ONL decreased (Figure 28E). A transient increased in IRs in the ONL appeared 
and the changes in the ESfL and the RGCL were unremarkable at 12 hours (Figure 
28F). At 24 hours (Figure 28G), the ONL showed overall decrease in clusterin IRs. 
At 96 hours (Figure 28H), strong clusterin IRs in irregular-shaped nuclei were noted 
in the ONL. Some scattered apoptotic body-like structures also showed strong IRs. 
VII.7.2. Grading of clusterin immunoreactivities 
Figure 29 showed the grading of clusterin IRs at the RGCL, INL and ONL of the rat 
superior retinas at various times after light exposure. There was no statistically 
significant differences among each group. It appeared the clusterin IRs increased in 
the ONL after light exposure and reached the peak value at 1 to 3 hours. After 3 
hours, the IRs decreased but elevated again at 96 hours. 
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Figure 27: Positive control for clusterin immunohistochemistry using 
epididymus from the Lewis albino rat. Note the moderate 
immunoreactivities (IRs) of isolated epithelial cells (arrow) of the 
epididymus from an adult Lewis rat. *: The lumen of epididymus. 
(DAB, X400) 
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Figure 28: Immunohistochemistry of clusterin in the superior retinas at 
various time after light exposure. (A) Normal unexposed retina: 
The retinal ganglion cell layer (RGCL), the inner nuclear layer (DS[L) 
and the outer nuclear layer (ONL) showed mild immunoreactivities 
(IRs). (B) 0; (C) 1; and (D) 3 hours: The RGCL remained 
unchanged but there was a gradual increase in IRs in the FNL and 
ONL with scattered nuclei showing more IRs (arrows). (DAB, X400) 
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Figure 28: Continued. 
(E) 6 hours: The RGCL was unremarkable. The ESfL and ONL 
showed mild decrease in IRs. Scattered nuclei in the ONL showed 
moderate IRs (arrow). (F) 12 hours: The RGCL and ESfL remained 
unchanged. The ONL showed an increase in IRs with scattered 
nuclei showing more IRs (arrows). (G) 24 hours: The IRs in the 
RGCL, ES[L and ONL subsided. (H) 96 hours: The RGCL and YNL 
remained unchanged. Scattered nuclei in the ONL showed strong IRs 
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Figure 29: Grading of clusterin immunoreactivities (IRs) in the superior 
retinas at various time after light exposure. There is no significant 
change in the overall IRs in all layers of the superior retinas after 
light exposure. RGCL: retinal ganglion cell layer; 1NL: inner nuclear 
layer; ONL: outer nuclear layer. * P < 0.05 when compared with 
normal. [Tukey' s Pairwise Multiple Comparison Test]. 
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DISCUSSION 
VII I .1. Summary 
In this study, we reproduced a previously described rat model of retinal 
degeneration induced by light in this laboratory. We employed an unique 
combination of light intensity and duration of light exposure (300-320 foot-candles 
for 3 hours) to generate a slow retinal degenerative process with little inflammatory 
reactions, and therefore allow us to examine the early changes of protein and mRNA 
expression before photoreceptor cell death. With this unique experimental protocol, 
we noted a similar outcome after photic injury in which there was a focal loss of 
photoreceptor nuclei (from 10-12 to 0-1 rows of nuclei per column in the most 
severely damaged region). The pathological features of the rat retinas in our study 
were similar to previous studies showing vacuolated inner (IS) and outer segments 
(OS), mild edema, densified nuclei and a focal thinning of the ONL particularly in 
the superior and temporal quadrants of the posterior retinas'6,58,69,70 These 
progressive histopathological changes paralleled the appearance of positive tdt-
mediated dUTP-biotin nick end labeling (TUNEL) which showed a maximal number 
at 24 hours after light exposure. However, morphometry of the averaged ONL 
thickness showed a significant loss of photoreceptor nuclei only at 96 hours after 
light exposure. Hence, morphologic changes preceded the appearance of TUNEL 
which also preceded the significant loss of photoreceptor cells. 
The overall immunoreactivities (IRs) of p53 using a grading system with 3 
different observers showed no significant change at the superior and inferior retinas. 
However, p53 IRs at the posterior part ofthe superior retinas showed a mild increase 
in IRs in scattered photoreceptor nuclei immediately after light exposure. This 
focally elevated level of IRs retained for 3 hours and then decreased gradually. At 
24 hours, there was a significant and focal loss of p53 IRs in the ONL but IRs 
recovered at 96 hours. Double-labeling of p53 and TUNEL revealed that 
fluorescent-IRs of p53 was always absent in TUNEL-positive nuclei in the ONL. 
However, not all p53 immuno-negative nuclei were TUNEL-positive. 
In situ reverse transcriptase-polymerase chain reaction (RT-PCR) of p53 
showed activation of p53 gene in the ONL immediately after light exposure with a 
maximal appearance of p53 mRNA at 3 hours after light exposure. At 6 hours, there 
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was a focal decrease of p53 reaction signals (RSs) but followed by a recovery at 96 
hours. Hence, there was a biphasic expression of p53 with the early phase showing 
an immediate increase of both p53 mRNA and protein level after light exposure and 
the late phase showing a recovery of its mRNA and protein. Immunohistochemistry 
and in situ RT-PCR of p53 suggested that loss of p53 mRNA preceded the 
degradation of p53 protein. Double-labeling suggested that the loss ofp53 IRs were 
linked to the appearance ofDNA nicks, and the accumulation of p53 protein was not 
associated with TUNEL. 
The overall IRs of p21 showed no significant changes at the superior and 
inferior retinas, except at 24 hours at which there was a mild decrease ofp21 IRs in 
both the retinal ganglion cell layer (RGCL) and the ONL. However, focal changes 
of p21 IRs in the posterior part of the superior retinas showed a biphasic up-
regulation of p21 similar to the focal IRs of p53, including an early increase, gradual 
decrease and fmal recovery. Double-labeling of p21 and TUNEL demonstrated that 
the photoreceptor cells with fluorescent-labeling of p21 showing a ring-like pattem 
were also TUNEL-positive at late time points such as 24 and 96 hours. Hence, this 
was similar to other systems showing that p21 was up-regulated in a p53-dependent 
pathways in response to stress336-339 in addition, accumulation of p21 protein may 
be associated with DNA nicks and sequestration ofaccumulated-p21 protein may be 
necessary for the progression ofDNA fragmentation. 
The average scores of bax IRs showed no significant changes at the superior 
and inferior retinas except there was a mild decrease at 1 and 12 hours after light 
exposure in the RGCL. However, focal bax IRs showed gradual increase in bax IRs 
in the ONL immediately after light exposure with maximal IRs at 6 hours. At 12 
hours, there was a sudden decrease and the level of IRs maintained up to 96 hours. 
In situ RT-PCR showed an overall increase ofbax mRNA expression in the superior 
and posterior retinas in the ONL at 1 hour and a decrease at 3 hours after light 
exposure. Hence, there was a 5 hours-time lag between the expression of bax 
mRNA and its protein accumulation in the ONL after light exposure. Even though 
bax protein expression paralleled the expression of p53 protein in our study, 
accumulation of bax alone was not associated with apoptosis of photoreceptor cells 
after photic injury. 
Morphometry of c-fos in the superior retinas showed an increase in the 
number of c-fos immuno-positive nuclei in the ONL immediately after photic injury 
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with a maximal number at 24 hours. Hence, the appearance of c-fos in the ONL 
paralleled the appearance of TUNEL showing the typical inner-to-outer and 
posterior-to-peripheral labeling. Therefore it seems that c-fos accumulation is 
associated with DNA nicks and probably necessary for the initiation of DNA 
fragmentation. 
The average scores of clusterin IRs showed no significant changes in the 
superior and inferior retinas. However, focal clusterin IRs showed a mild increase in 
the superior retinas immediately after light exposure with a maximal IRs at 3 and 12 
hours. At 24 hours, the IRs subsided but at 96 hours, scattered photoreceptor nuclei 
in the superior retinas showed moderate IRs again. Hence, immunohistochemistry 
of clusterin showed no parallelism with indices of cell death in the ONL. On the 
contrary, clusterin appeared to have a protective role in the ONL that enhanced 
tissue repair after light damage355，38i，389，403,4i9. 
VIII.1.1. HistopathoIogy & morphometry 
In our study, vacuolation of the inner (IS) and outer segments (OS) together 
with edema of the outer plexiform layer (OPL) and the outer nuclear layer (ONL) 
were the earliest morphologic changes after light exposure. The edema and dense 
nuclei initially appeared in the inner part of the ONL and spread to the outer part. 
Granulation was noted in the retinal pigment epithelium (RPE) at early time points. 
The early changes in the OS was consistent with the hypothesis that free radicals 
being generated after light exposure will first target the outer segments (OS)36,i43 in 
which there is the highest concentration of polyunsaturated fatty acid, the preferred 
reactants in lipid peroxidation, in the bodyi4i,i42. jt [^  possible that with lipid 
peroxidation, the OS membrane fails to maintain the normal physiological ions 
exchange of the cell such as Na+ and K+ ions and ends up with influx ofexcess water 
leading to vacuolation and edema in the IS and OS. The biochemical reasons for the 
first appearance of edema at the inner part of the ONL are not clear. However 
edema of the OPL and ONL, vacuolation of IS and OS, and the granulation in RPE 
probably represent the universal response to stress before photoreceptor cell death!6. 
Since the susceptibility of the retina to light damage is heterogeneous, the 
morphometric analysis we employed, which measured the total areas ofthe superior 
retinas over its corresponding length, is not the most sensitive indicator offocal cell 
loss. There was mild thinning of the ONL in focal areas in earlier time points as 
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shown in our morphologic study but the average thinning ofthe ONL only became 
significant at 96 hours after light exposure. The extent of edema may affects the 
accuracy ofthe actual ONL thickness and probably accounts for the mild increase of 
the ONL thickness at 3 hours and mild decrease ofthe ONL thickness from 3 to 24 
hours after light exposure. Hence, for our purpose, the descriptions offocal changes 
as illustrated by the photomicrophages are more representative. 
VIII.1.2. In situ TUNEL 
Our in situ TUNEL analysis was consistent with previous study69 showing 
apoptotic loss of photoreceptor cells after photic injury. More TUNEL-positive 
nuclei were consistently observed in the superior than the inferior quadrants of the 
rat retinas and they spread from the inner aspect of the ONL to the outer. These 
spatial and temporal sequences ofTUNEL appearance (superior to inferior quadrant; 
inner to outer ONL) paralleled the histopathological changes showing focal edemI 
and densified nuclei in the ONL. Hence, our morphologic, TUNEL and 
morphometric data suggested that morphologic changes precede DNA nicks which 
precede the actual loss ofphotoreceptor nuclei. 
Our preliminary study (data not shown) using electron microscopy (EM) 
revealed that some nuclei in the inner nuclear layer (INL) also showed densified 
chromatin but there was no noticeable TUNEL-positive nuclei. This observation 
suggested that the cells in the INL may die through a pathway different from the 
photoreceptor cells43o,43i or that TUNEL may not be the specific marker of 
a p o p t o s i s 4 3 2 - 4 3 4 . Howcver, it is possible that there are apoptotic cell death systems 
with no DNA nicks. The absence of labeling may also due to the low sensitivity of 
TUNEL method. To further examine the specificity of TUNEL method in our 
study, TUNEL labeling in EM level may help to clarify this problem. IfTUNEL is a 
specific marker, all cells with apoptotic features such as chromatin margination 
should be labeled. 
Vm.l.3. p53 & c-fos 
Our grading ofimmunohistochemistry ofp53 showed no significant changes 
in the expression of p53 protein in the ONL after light exposure except on 24 hours 
when there was a mild decrease. Grading ofp53, other immunohistochemistry and 
RT-PCR reaction signals, similar to morphometry of the ONL thickness, is not an 
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adequate method to document the changes in p53 immunohistochemistry because it 
is an overall average while apoptosis of cells in the ONL is focal. Method of 
western blotting may also be applied in this study but it is only an average and 
probably is less sensitive than the focal changes of IRs in the ONL. Hence, focal 
qualitative description allows us to detect the least changes in this system. 
In situ RT-PCR is a powerflil tool but many cautions should be made to 
prevent false results. Even though the results of in situ RT-PCR may not be highly 
reproducible, sections with proper controls are still informative. In our study, we put 
three adjacent paraffin sections on the same slide. One of them is the experimental 
one and the other two serve as controls: 1) positive control: in situ PCR to amplify 
the specific fragment of genomic DNA. DNase treatment and reverse transcription 
were omitted in this control; and 2) negative control: pretreatment with DNase and 
omission of the reverse transcription. In our experience, we found that the step of 
protease digestion is one of the most critical steps in in situ RT-PCRH3,435 which is 
consistent with what other previous studies have suggested. In this study, we also 
took precautions in fixation time and in processing of the tissue samples. We kept 
the time of fixation constant and try to process all the tissue samples together to 
minimize the variations in the extent of protease digestion among samples. Since 
the duration of fixation might affect the quality of DNA for genetic study and 
formalin fixation has a deleterious effect on the DNA, fixation time should be 
always kept as short as possible. In general, PCR products greater than 500 b.p. 
were not recommended for in situ RT-PCR since the DNA was usually randomly 
fragmented during processing and after embedding into paraffm block435. However, 
if the size of the PCR product is too small (< 100 b.p.)，it may easily lead to 
mispriming. Therefore cautions should be taken when designing the primer probes 
for the specific DNA sequences. Our experimental conditions on in situ RT-PCR 
had taken all these variables into consideration. 
The result of in situ RT-PCR of p53 shows a biphasic up-regulation of p53 
mRNA. The first phase may be related to a general response to stress and the late 
phase may be related to the recovery of the tissues. The down-regulation between 
these two phases may be related to the process of cell death since the TUNEL-
positive nuclei appeared initially along the inner aspect ofthe ONL and spread to the 
outer aspect69 which is similar to the loss ofRSs in p53 mRNA. 
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When combined with the results of p53 immunohistochemistry, in situ RT-
PCR and TUNEL, we noticed that there was a significant change in p53 mRNA 
expression without significant change of its protein except at 24 hours. The time of 
the lowest IRs and RSs of p53 was at 24 hours after injury and coincided with the 
peak appearance of TUNEL，suggesting that p53 is not required for photoreceptor 
cell death. However, how photoreceptor cells acquired the sustained level of p53 
protein, which has short half-life time in the normal state, in the absence of 
translational up-regulation is not known. One possible reason is that the antibody 
we applied may cross-react with some unknown p53-like proteins. Another 
possibility is that the p53 protein is somehow stabilized by some p53 binding 
proteins that enhance its half-life. It was known that p53 can form complex with c-
Abl and mdm2 but whether these complexes may prolong its half-life is 
unknown273,333. Conformational changes of p53 after phosphorylation andA)r 
dephosphorylation may also stabilize the protein436. 
/« vivo p53 is known to be multiple phosphorylated by different protein 
kinases at specific sites after multiple stimulp26,231-234,238,241,437^ 44_ Site-specific 
phosphorylation of p53 was known to modulate its function. In general, 
phosphorylation at the N-terminal (at serine 15 and 34) enhances its responses to 
growth factor, U.V. light, oxidative stress and DNA damage233,238,445 while 
phosphorylation at the C-terminal (serine315 and 392 in humans and serine 386 and 
389 in mice) enhances the sequence-specific DNA binding ability ofp53, assists the 
transition of a latent p53 to an activated form which is capable ofsequence-specific 
transcriptional activation such as p21 and mdm222M46, and enhances the ability to 
repress c-fos expression^^i. 
At 1 hour after light exposure, moderate IRs o fp53 were noted in Miiller 
cell-like nuclei in the EML. Since the IRs of Miiller cells were focal, mainly in the 
posterior retina, but not throughout the whole retina, it is likely that the activation of 
p53 in Miiller cells is associated with photoreceptor cell death after light damage. 
Our results on fluorescent-labeling ofp53 in the double-labeling study were 
very different from those developed by immuno-peroxidase reactions using DAB. 
Fluorescent-labeling showed sustained high levels of fluorescein-tag p53 protein in 
the ONL and IS of the retina immediately after photic injury followed by an acute 
and generalized loss of fluorescent IRs. At late time points, similar to single 
labeling of p53 protein, the p53 fluorescent IRs recovered but not back to its basal 
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level before light damge. These changes in fluorescent labeling paralleled the RSs 
of in situ RT-PCR, suggesting that the results of double-labeling may be more 
consistent and reliable than single-labeling using DAB. We believed that the 
differences may due to the higher sensitivity and specificity of the fluorescent 
marker than DAB. 
We noted that all TUNEL-positive nuclei in the ONL were p53 immuno-
negative but not all immuno-negative cells were TUNEL-positive. The absence of 
p53 fluorescent IRs in TUNEL-positive nuclei may due to the inhibitory effect of 
DAB on the labeling ofthe fluorescent-tag. However, it was unlikely as our positive 
control (M13-8) showed co-localization ofp53 fluorescent immunohistochemistry 
and TUNEL. Another possibility is that TUNEL may not be as sensitive as the 
immunohistochemistry of p53. However, TUNEL is expected to be highly sensitive 
because ofthe involvement of enzymatic reactions. Hence, it is likely that there is a 
narrow window between p53 protein suppression and DNA fragmentation in 
photoreceptor cells after photic injury. The suppression ofp53 protein may also be 
necessary for the activation of other "cell-death genes". 
Based on our observation, it appeared that after photic injury, p53 protein is 
suppressed while c-fos is up-regulated, p53 protein is known to inhibit c-fos mRNA 
expression by at least two mechanisms: 1) it binds to the c-fos promoter and inhibits 
the latter's transcription3n,346and 2) it activates bcl-2 which indirectly inhibits c-fos 
expression by decreasing cytosolic free Ca'+ level447,448. c-fos can also be induced 
by many other pathways, such as those mediated by receptor-ligand interactions, 
voltage-sensitive calcium channels, neurotransmitters, depolarizing stimuli and 
protein kinases447. Assuming a down-regulation of p53 mRNA, followed by an 
immediate down-regulation of the p53 protein and the activation of c-fos in 
responses to acute down-regulation of p53 protein, a larger number of c-fos 
immuno-positive nuclei should be observed in our study. Therefore, we speculated 
that the activation ofc-fos in our study may not entirely due to the down-regulation 
of p53, at least not in the mRNA level. In addition, it is unlikely that p53 protein 
regulates c-fos in our system because the results of p53 immunohistochemistty 
showed no obvious overall changes ofp53 protein expression throughout our study 
period. These observations further suggested that the activation ofc-fos is unlikely 
due to the down-regulation of p53 protein. However, even in the presence ofp53 
protein as shown in our single labeling study ofp53, selectively dephosphorylation 
at the C-terminal of the p53 protein by specific protein phosphatases may enhance c-
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fos e x p r e s s i o n 2 4 i . The recent study by Marti et al. demonstrated that the 
photoreceptor cells of p53-/- mice die through c-fos-dependent apoptosis after photic 
injuryio3，io4, suggesting that the presence of p53 is not required to inhibit c-fos 
expression under normal condition. Further experiments on double labeling of c-fos 
and p53 may help to explore this possibility. 
Our study is the first to demonstrate that the c-fos protein accumulated in the 
photoreceptor nuclei after photic injury by immunohistochemistry. The pioneer 
work by Hafezi et al. represented the first attempt to probe the expression of c-fos in 
photoreceptor cells by in situ hybridization after photic injuryio4 According to 
Hafezi (Oral communication, ARVO 98 annual meeting), they failed to show 
positive labeling of c-fos with immunohistochemistry. Our success may due to our 
use of antigen retrieval procedures. Hafezi's group showed accumulation of c-fos 
mRNA both in the RGCL, INL and ONL immediately after photic injury in mice 
while we noted an exclusive accumulation of c-fos protein in the ONL only. This 
difference was unlikely due to different physiological responses to light between 
mice and rats because it was also reported that c-fos can be induced by light in the 
RGCL and INL and by darkness in photoreceptor cells in rat as in mice^07 xhus, we 
proposed that c-fos protein was somehow translationally up-regulated in a very 
efficient way in the ONL but not in the RGCL and INL, even in the presence of c-
fos mRNA. However, this possibility remains to be verified. 
VIII.1.4. p21 
The changes in p21 IRs paralleled the expression of p53 mRNA and agreed 
with previous studies suggesting that p21 is one of the downstream effectors of 
p53336-339. However, we were unable to establish a correlation between the overall 
IRs grading of p53 and p21. The reason, as we have discussed before, may due to 
the insensitive andA>r non-specific labeling of p53 protein by immuno-peroxidase 
reaction using DAB. In response to DNA damage in many other systems, the level 
ofp53 increases and acts as a transcriptional activation of p2P20.334,336,449, Being a 
specific cyclin-cyclin dependent kinase inhibitor320’336,339，accumulation of p21 will 
arrest the cell at G, phase to allow DNA repair. Further experiments on 
immunohistochemistry using specific cell cycle markers may help to examine the 
changes of cell cycle machinery in photoreceptor cells after photic injury. However, 
p21 can also be activated through a p53-independent pathways in some 
systems450,45i. It was known that p21 can be induced by reactive oxygen species 
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(ROS) independentof p53452,453. Since light-induced damage to the retina also 
involved ROS, accumulation of p21 as shown in our study may be mediated through 
p53-independent pathways. Further study on double-labeling of p53 and p21 may 
help to address this question. Our result of double labeling of p21 and TUNEL 
demonstrated the co-localization of p21 protein and DNA nicks suggesting that 
accumulation of p21 may be associated with photoreceptor cell death. Since p21 is 
not known to cause apoptosis in most systems454"457, we postulated that the 
accumulation of p21 may simply be the response instead of a triggering signal to 
apoptosis. However, the former possibility cannot be ruled out. Our findings also 
suggested that sequestration of p21 protein into the cytoplasm may be necessary for 
the progression of apoptosis. Further experiment on p21 knockout mice after photic 
injury may help to explore this possibility. 
VIII.2.5. bax 
Immunohistochemistry of bax suggested that bax is behind p53 mRNA 
expression as well as p21 protein. Hence, our results agreed with other studies 
suggesting up-regulation of bax protein depends on the accumulation of p53 
protein33i. However, the results of bax in in situ RT-PCR were different from the 
grading ofbax IRs. The highest level ofbax mRNA was detected at 1 hour that was 
5 hours ahead of the highest bax IRs. It is unlikely that there is such a long delay 
between mRNA expression and protein accumulation. The reason for this 
discrepancy is not clear and remains to be determined. Even bax gene was known to 
be activated in a p53-independent pathway45846i, we believed that up-regulation of 
bax is mediated through p53-dependent pathways in our study460,462 However, our 
results suggested that bax alone is not associated with photoreceptor cell death. 
Nevertheless, whether there is an alteration of the bax^cl-2 ratio in photoreceptor 
cell death is unclear463. in addition, an unpublished data by Chang464 has shown the 
up-regulation of bcl-2 in scattered photoreceptors in the ONL after 24 hours 
continuous light exposure, suggesting the possible involvement of bcl-2 in light-
induced photoreceptor cell death. Ifbax is transactivated by p53, it is interesting to 
note that there is generalized increase of p53 protein in the ONL but only a few 
scattered nuclei showed bax IRs throughout the ONL. Thus, as we have mentioned 
before, it is likely that there are heterogeneous modifications of p53 proteins by 
phosphorylation/dephosphorylation in the ONL after photic injury. 
Vm.l.6. CIusterin 
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Clusterin immunohistochemistry showed elevated expression of clusterin 
immediately after photic injury. The up-regulation of clusterin may represent an 
early response to stress. However, the highest IRs of clusterin were observed at 96 
hours. It was known that clusterin may be activated by AP-P83. Thus, before the 
experiment, we postulated that expression of c-fos may be followed by the acute 
expression of clusterin. However, our immunohistochemistry of c-fos and clusterin 
showed otherwise suggesting that clusterin may not be involved in the induction of 
apoptosis. The possible role of clusterin in late apoptotic changes is to separate the 
injured from healthy photoreceptor nuclei by acting as a barrier between healthy 
tissue and membrane-active biological fluids^^s. Clusterin may also assist in the 
maintenance of tissue integrity and to enhance tissue repair by eliminating excessive 
lipids derived from dead or injured cells or to scavenge toxic lipid by-products or 
enhance synaptic reorganization in the injured areas403,4i9,465 Previous studies have 
shown that clusterin is up-regulated both in tissues associated and not-associated 
with apoptosis in rd and rds mice"i,465, as well as in light-induced retinal damage in 
albino ratsH2,464. Therefore, further experiments on double labeling of clusterin and 
TUNEL in our model may help to examine the relationship between clusterin and 
apoptosis. 
VII I .2. Hypothesis 
In summary, our findings are consistent with the pathways as illustrated in 
Figure 30 showing a pivotal role ofp53 in the regulation of photoreceptor cell death. 
We proposed that under normal conditions, high level of p53 was maintained 
in the photoreceptor nuclei. Accumulation of p53 is necessary to prevent 
overexpression of c-fos3"，346 and a high level of p53 may transcriptionally activate 
the bcl-2 expression3i3,3i4. The high level of bcl-2 (i.e. low ratio ofbaxyTDd-2) then 
prevents the activation of CPP32 (caspase-3) which in tum may lead to cleavage of 
poly-adenosyl-ribose polymerase (PARP) followed by cell death after depletion of 
energy466,467. bcl-2 may also inhibit c-fos induction by decreasing the intracellular 
calcium leveF47,448. Accumulation of p53 may also be responsible for the repression 
of iNOS gene expression, thus reducing the potential for NO-induced DNA 
damage3i5. 
In response to oxidative damage after light exposure, p53 was activated and 
















































































































































































































































































































prevent the instability of cell cycle after DNA damage to allow DNA repair. 
However, ifDNA failed to be repaired, there would be a programmed suppression of 
p53 by initiating a cascade of apoptosis: 1) p21 protein may decrease and then the 
cell escape from Gi phase and execute programmed cell death339; 2) intracellular 
Ca2+ may increase indirectly by down-regulation of bcl-2448. Ca�+ is an important 
modulator in apoptosis that triggers a series of events such as (a) activation of 
Mg2+/Ca2+-dependent endonuclease468470; (b) activation of calpain304,305 (a calcium 
activated protease) that leads to the breakdown of cytoskeleton and (c) activation of 
nitric oxide synthase that enhances the formation of cytotoxic free radicals47M72; 3) 
down-regulation ofbcl-2 may also initiate the release of activated CPP32 and PARP 
which lead to cell death466; and 4) c-fos may be overexpressed once p53 was 
suppressed3n. Accumulation of c-fos may lead to (a) formation of AP-1 when 
complexed with c-jun and regulation of those genes that associated with cell 
death473,474. (b) transcriptional up-regulation of the serotonin N-acetyl transferase 
and tryptophan hydroxylase genes that lead to the biosynthesis of melatonin475"477 ^ 
has been demonstrated that melatonin enhanced light-induced damage of 
photoreceptor cells in rats47M79. Melatonin is also a neuromodulator that inhibits 
dopamine release in the retina that further leads to an increase of intracellular cAMP 
formation in photoreceptor cells476，478. in some systems, overexpression ofcAMP is 
associated with apoptosis480-482. The proposed pathways were supported by our 
findings and previous studies that showing Ca�+ channel blocker (Flunarizine)67, 
CPP32 inhibitor (YVAD)483, PARP inhibitor (3-ABA)483, NOS inhibitor _ A ) 4 8 3 
and D2 dopamine receptor agonist (Bromocriptine)478 were able to ameliorate the 
damage after photic injury in rats. Our preliminary data also showed up-regulation 
of PARP and calpain after photic injury in our model O^ot shown). These previous 
studies further confirm the photoreceptor cells die through apoptosis with the 
involvement of free radicals, caspase and indicated the importance of Ca:+ in 
regulating photoreceptor cell death. 
VII I .3. Conclusions 
We reproduced a rat model of retinal degeneration induced by light with an 
unique combination of light intensity and exposure duration. Under our hand, the 
retinal degeneration was slow with focal loss of photoreceptor nuclei together with 
mild edema of the ONL and OPL, vacuolation of the IS and OS and granulation of 
the RPE. The histopathological changes of the ONL paralleled the appearance of 
nuclei with DNA nicks as demonstrated by TUNEL. Our morphological and 
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morphometrical studies suggested that the morphologic changes preceded the 
appearance ofTUNEL which also preceded a significant loss of photoreceptor cells. 
Our studies showed parallelism to the expression of p53, p21 and bax. p21 
accumulation appeared to associate with cell cycle arrest and apoptosis of 
photoreceptor cells. Accumulation of bax protein alone appeared not to associate 
with apoptosis. Suppression of p53 expression seems to be necessary for the up-
regulation of c-fos protein in which its accumulation associates with TUNEL and 
photoreceptor cell death. Clusterin appeared to be up-regulated in a AP-l(c-fos/c-
jun)-independent pathway and associated with tissue repair and remodeling but not 
apoptosis. 
We proposed that p53 plays a pivotal role in maintaining the integrity ofthe 
photoreceptor cells in rat retinas. Under oxidative stress after light exposure, certain 
signals somehow activate the cell cycle machinery and the cell cycle escapes from 
Go phase. Accumulation of p53 may up-regulate p21 which arrests the cell cycle at 
Gi phase for DNA repair. If DNA fails to be repaired, p53 is suppressed and 
therefore leads to acute up-regulation of c-fos protein, c-fos protein acts as a 
transcription factor when complex with c-jun and this complex (AP-1) may activates 
the "cell death" genes or suppress the "survival" genes. 
It was well known that so far, p53 mutation accounts for >50% of human 
brain tumors249,250. Since photoreceptor cells belong to the central nervous system, 
we therefore believe that accumulation of p53 may play an important role in 
induction of apoptosis of photoreceptor cells at the beginning of the experiment. 
However, instead of accumulation, suppression of p53 was noted in photoreceptor 
cells before DNA fragmentation. Even though p53 was suppressed before cell 
death, we believe that regulation of p53 plays a pivotal role in photoreceptor cell 
survival after damage. Since sequestration of p21 protein was noted in 
photoreceptor nuclei with DNA nicks and accumulation of c-fos appeared to precede 
DNA fragmentation, any therapeutic agents aim at maintaining a high level of p53 
and p21 protein or suppressing the expression of c-fos in the photoreceptor nuclei 
may rescue or delay programmed cell death in photoreceptor cells after injury. 
However, this remains to be determined. 
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